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Summary  
The two following projects reported were undertaken as part of the masters of 
research in molecular and cellular biology. The first project takes a look at the 
emerging fungal pathogen Cryptococcus neoformans and how one of its known 
virulence factors, phospholipase B, controls cell morphology. We investigated the 
knockout strain and their changes in cell size and nuclear content, after phagocytosis 
by murine macrophages, along with other stresses, to investigate whether 
phospholipase B may in involved in the regulation of titan cells. Results from the 
study showed that during infection both nuclear content and whole cell size of the 
phospholipase B knockout C. neoformans strain increased over 18 hours, but further 
study will need to be undertaken to conclusively prove this observation. The second 
project changes kingdom and investigates bacterial cell signalling. Bdellovibrio 
bacteriovorus is a predatory bacterium, which is known to predate other Gram-
negative bacteria. The molecular basis of how this bacterium goes from ‘bite’ to 
invasion has been shown to require Cyclic-di-guanosine monophosphate signalling. 
In this study we have attempted purification and structural analysis of 4 proteins that 
are believed to be involved in the initial bite and downstream signalling within B. 
bacteriovorus and have documented the outcome within. 
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Abstract Project 1- Cryptococcus neoformans phospholipase B and its influence on 
fungal cell morphology 
Cryptococcus neoformans is an opportunistic intracellular fungal pathogen and is a 
causative agent of Cryptococcal meningitis, which kills more than 500,000 a year. 
Phospholipase B (Plb1) has been implicated in host survival as well as resistance to 
macrophage uptake and particle killing. Plb1 knockout cells have been observed 
increasing in size once phagocytosed, these cells may possibly be precursors to titan 
cells, which are involved in modulating the host immune system. The aim of the 
project was to determine whether these enlarged Plb1 knockout cells are indeed 
precursors of titan cells through observations of certain markers specific for titan 
cells, such as increased nuclear content. Wild type, mutant and reconstituted cells 
were measured for cell size increase and for nuclear content in J774.1 macrophages 
and macrophage lysate. After 18 hours of infection within macrophages a greater 
proportion of the Plb1 knockouts showed an enlarged cell size and an increased 
amount of nuclear content, greater than that of the wild type and reconstituted 
strains.  While it is not conclusive proof that these larger cells are true 
representatives of different morphologies it poses interesting questions about how 
Plb1 is involved in fungal cell morphology. 
Keywords: Cryptococcus neoformans, Titan cells, Phospholipase B, Cell 
morphology, Flow cytometry
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Abstract Project 2 - A study into proteins proposed to be involved in C-di-GMP 
signalling and predation from Bdellovibrio bacteriovorus – Bd1483, Bd1996, Bd2538 
and Bd3100. 
Bdellovibrio bacteriovorus is a predatory Gram negative bacterium of the δ-
proteobacteria, and known to predate on other Gram negative bacteria. It has been 
suggested that this could one day be used as a ‘living antibiotic’ but much of the 
underpinning biology of the bacterium remains to be uncovered. A pathway yet to be 
defined is the signal pathway from the initial ‘bite’ to invasion into the prey periplasm. 
This study attempts to uncover information regarding the mediators of the cyclic-di-
guanosine monophosphate (C-di-GMP) signal that is required for invasion, as well as 
possible prey recognition proteins.  The proteins studied were Bd1483, a von 
willebrand type A domain containing protein, Bd2538, a predicted lipid binding protein 
and Bd1996 and Bd3100, both of which contain PilZ domains, known to bind C-di-
GMP, and domains that are predicted glycine-tyrosine-phenylalanine (GYF) domains, 
which are known to bind polyproline sequences. With the initial aim of expressing 
these proteins in E. coli and purifying them for structural and biochemical 
characterisation, we have shown that Bd1483 is soluble upon overexpression, and 
crystalizes readily. Bd1996 is soluble, but unstable when crystallization was 
attempted. Bd3100 is insoluble upon expression and Bd2538 remains to be cloned 
successfully. 
Keywords: Bdellovibrio bacteriovorus, Cyclic-di-GMP, Invasion, Predation, 
Protein purification  
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1. Introduction 
Cryptococcus neoformans is an opportunistic fungal pathogen, and it is the primary 
cause of cryptococcosis in immunocompromised patients, which often leads to 
meningioencephalitis and death (figure 1) (Lin and Heitman 2006, Voelz and May 
2010, Johnston and May 2013, Cogliati 2013). While normally a soil dwelling 
organism associated with guano and wooded areas, contact with the fungi is 
common. A study by Goldman et al., 2001 found that a majority of children over the 
age of two tested seropositive for C. neoformans (Lin and Heitman 2006, Voelz and 
May 2010, Johnston and May 2013). While it is known that melanin and the 
polysaccharide capsule produced by the fungi contribute heavily to its virulence, 
there has been a recent surge in interest around the secreted lipid modifying enzyme 
phospholipase B (Plb) and how it influences the interaction between C. neoformans 
and the host’s immune system (Ghannoum 2000, Steenbergen and Casadevall 
2003, Santangelo et al., 2004, Jones et al., 2007 Wright et al., 2007). Plb has been 
shown to be required for full virulence in C. neoformans, as well as normal cell 
function (Cox et al., 2001). Deletion of the gene lowers the virulence of the pathogen 
in the murine model and reduces adhesion to cultured lung epithelium (Cox et al., 
2001, Ganendren et al., 2006). Due to the relatively recent surge in HIV-infected 
individuals the amount of cryptococcosis cases have increased dramatically, leading 
to more deaths a year being attributed to cryptococcal meningitis than tuberculosis 
(WHO 2011, Park et al., 2009). Due to this, there is a need to understand how this 
pathogen’s virulence factors contribute to host interactions and disease. With the 
hopes of one day targeting these virulence factors to aid treatment of this disease.  
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1.1 The biology of Cryptococcus spp. 
C. neoformans, shown in figure 1, is a yeast belonging to the basidiomycetes family 
of fungi. While it is a saprophyte, normally, it has the ability to infect humans whose 
immune systems are compromised (Ruiz et al., 1989, Voelz et al., 2010, Johnston 
and May 2013). While it has not evolved to be a pathogen of mammals it is believed 
to have evolved the ability to survive within predatory amoebas, which have 
similarities to mammalian phagocytic cells (Steenbergen and Casadevall 2001, 
Steenbergen and Casadevall 2003 Chrisman et al., 2010 Chrisman et al 2011). 
Figure 1. A cartoon diagram of a cryptococcal cell.  
Adapted from Simmer, M., 2003.  
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Historically, cryptococcosis was thought to be caused by a single agent, C. 
neoformans, but recently 5 serotypes have been identified through capsular 
agglutination to differentiate between the causative agents (Dromer et al., 1993, Lin 
and Heitman 2006, Voelz and May 2010). Of these strains A, D and A/D belong to 
the species C. neoformans, while B and C (once thought to be of the C. neoformans 
species) have been accepted as a different species C. gattii, which is associated with 
infection of immunocompetent patients (Lin and Heitman 2006, Byrnes et al., 2010, 
Voelz and May 2010).   
1.1.1 C. neoformans reproduction  
C. neoformans mating types are defined by the mating type locus (MAT), which is 
found in many fungi (Metin et al., 2010). In clinical isolates the α sex of C. 
neoformans predominates, and undergoes asexual budding, rather than sexual 
reproduction with the ‘a’ sex, both in vitro and in the host (Lin et al., 2005, Metin et 
al., 2010). C. neoformans contains a second mating type a. When nutrients become 
limiting and starvation occurs the two mating types secrete pheromones then fuse 
and sexual reproduction occurs (figure 2) (Lin et al 2006). The nuclei of the fused 
cells do not yet recombine and a dikaryon filament then grows. Basidia form at the 
tips and this is where nuclear fusion between the two mating type nuclei occurs 
(figure 2) (Nielsen et al., 2003, Lin et al., 2006, Kronstad et al., 2011.). Meiosis and 
mitosis occur at the basidia forming many haploid basidiospores along 4 distinctive 
chains (Lin et al., 2005) (figure 2). These basidiospores are then released into the 
environment, and are thought to be the main route of infection in humans (Nielsen et 
al., 2003, Lin et al., 2005). Spores then germinate into haploid yeast cells. Although 
this mating has been observed under laboratory conditions there have been 
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questions on how a population that has a unisexual majority could maintain a sexual 
reproduction cycle in nature. Lin et al., 2005 put forward a mechanism, where-by two 
cells of the same mating type (α) could sexually reproduce by ‘fruiting’. So, when 
under nutrient starvation the fusion of C. neoformans of the same mating type, 
monokaryotic diploid hyphae form (figure 2) (Lin et al., 2005). This leads to basidia 
formation, sporulation and release of spores, similar to the sexual reproduction cycle 
between different mating types (Lin et al 2005, Metin et al 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sexual and asexual 
reproduction in C. 
neoformans 
In sexual reproduction spores 
cell of different mating types 
fuse to form a dikaryon filament. 
At the tip of the filament, 
basidium, nuclear fusion and 
meiosis occur. Haploid 
basidiospores form along 4 
chains, which are then 
dispersed into the environment 
to germinate into haploid cells.  
Asexual reproduction, 
monokaryotic mating, occurs in 
a similar mechanism but with a 
diploid monokaryon filament 
forming which leads to meiosis 
in the basidium and sporulation, 
similar to sexual reproduction.  
Reproduced from Kronstad et 
al., 2011. 
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1.2 Epidemiology of C. neoformans 
Along with other infections related to HIV immunocompromisation, C. neoformans 
has had a recent emergence as a major pathogen of immunocompromised patients 
(Park et al., 2009). Due to its association with patients infected with HIV/AIDS it is not 
surprising that sub-Saharan Africa (SSA) shows a high incidence of cryptococcosis, 
but what may seem more surprising is that in 2006 deaths attributed to cryptococcal 
meningitis were greater than that of tuberculosis (Park et al 2009).  In 2011 the world 
health organization (WHO) attributed 500,000 deaths per year to cryptococcal 
meningitis in SSA. While in SSA, up to 65% of HIV related fatalities belong to 
cryptococcal infection, which is staggeringly high when compared to other areas of 
the world where it causes around 20% of HIV-related deaths (Park et al., 2009).  
While C. neoformans is associated with regions of high HIV-related burden, the 
recently defined species, C. gattii, is not. C. gattii is an emerging pathogen of 
immunocompetent patients, with most cases occurring around Papua New Guinea 
and Australia; typically tropical and sub-tropical regions and the fungi are found to be 
associated with eucalyptus trees (Voelz et al., 2010). In 1999, there was an outbreak 
of a hyper-virulent strain, known to replicate within macrophages. Since the outbreak 
in 1999 over 400 people across north western Canada and America have been 
infected with this virulent C. gattii strain (Byrnes et al., 2003, Voelz et al., 2013).  
1.3 Host-pathogen interaction 
Infection with C. neoformans normally occurs through inhalation of spores from the 
environment, leading to an initial interaction with the host immune system in the 
lungs (Goldman et al., 1994, Eisenmann et al., 2007). In the lungs the primary 
interaction with the host immune system is with the alveolar macrophages, which are 
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recruited when infection is detected (Eisenmann et al., 2007, Kechichian et al., 
2007). Normally, pathogens are detected by the macrophages through opsonic and 
non-opsonic receptors found on the macrophage surface, but C. neoformans 
generally avoids detection by non-opsonic receptors and is detected by opsonic 
receptors, including Fc receptor and CR3 receptors, which bind to opsonins 
deposited on the surface of the pathogen and enhance phagocytic uptake (Voelz and 
May 2010, Johnston and May 2013). The capsule has been implicated in preventing 
uptake, by masking the fungal cell wall from macrophage mannose receptors, as well 
as inactivating C3b, an opsonin deposited on the fungal surface (Kozel and 
Pfrommer 1986, Voelz and May 2010). Along with the capsule, anti-phagocytic 
protein 1 (App1) blocks complement receptor mediated phagocytosis by binding 
directly with the CR3 and CR2 receptors preventing them from binding to the 
deposited opsonins (Stano et al., 2009).  
1.3.1 Life with the macrophage 
Once a particle (or pathogen) has been phagocytosed, a series of events leads to the 
degradation of the particle in the phagosome. This normally occurs through a 
sequential maturation of the phagosome, with active compounds being sequestered 
to the phagosome, which are involved in killing and degrading foreign objects. C. 
neoformans, as well as other intracellular pathogens, have evolved ways of 
subverting this maturation process (Tucker and Casadevall 2002, May and Johnston 
2013, Smith and May 2013). Certain pathogens, namely Mycobacterium tuberculosis, 
have evolved ways to subvert phagosome maturation by evolving with humans over 
millennia; C. neoformans (and related species) appear to have not evolved this trait 
through co-evolution with humans. It is believed that this ability to subvert 
	  7	  
	  
phagosome maturation has come about through evolutionary interactions with soil 
amoeba (Steenbergen et al., 2001, Hershkovitz et al., 2009, Chrismann et al., 2010, 
Chrismann et al., 2011). Acanthamoeba are known to predate bacteria and fungi in 
the soil, and it has been shown that C. neoformans has strategies to prevent 
degradation and escape after being engulfed (Chrismann et al., 2010). This predation 
has also been implicated in maintenance of pathogenicity in the environment, with 
exposure to the predatory amoeba Dictyoselium discoideum enhancing virulence in a 
mammalian host (Steenbergen et al., 2003).  
As with M. tuberculosis, if the infection cannot be handled at the initial site of 
infection, the immune system changes from destruction of the pathogen to 
containment, leading to latent cryptococcal disease (Shibuya et al., 2005). This 
containment in similar to tubercular containment and is also orchestrated by CD4+ T-
helper cells and requires alveolar macrophages (Hill et al., 1992). When the immune 
system becomes compromised and weakened this containment breaks down leading 
to reactivation and possible dissemination of disease to the CNS (Shibuya et al., 
2005).  
Dissemination of the cryptococci to the CNS is believed to be due to its ability to 
persist and replicate within host macrophages (Eisenmann et al., 2007, Johnston and 
May 2013, Smith and May 2013). TNF-α has been implicated in prevention of 
dissemination of cryptococci, and C. neoformans is known to modulate host TNF-α 
(Chaka et al., 1997, Eisenmann et al., 2007). The ‘Trojan horse model’ of 
cryptococcal dissemination describes a scenario whereby survival within the 
macrophage allows cryptococci to evade the immune system and non-lytically expel 
(vomocytosis) from the circulating macrophages, once they pass near the brain (Ma 
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et al., 2006, Eisenmann et al., 2007). The reason and mechanism of this 
neurotropism has yet to be discovered, but it is suggested that C. neoformans’ ability 
to use neuronal transmitters, such as epinephrine to produce melanin, may be a 
reason for this tropism to the CNS, but this still remains unproven (Casadevall et al., 
2000, Steenbergen and Casadevall 2003, Casadevall 2010). C. neoformans must 
first cross the blood brain barrier (BBB) to infect the brain. It has been proposed that 
while it is hidden within the circulating macrophage, when the macrophage passes 
through the BBB cryptococci to can expel from the macrophage and enter the brain, 
but in vitro data suggests C. neoformans can pass through the BBB without the 
assistance of macrophages, via transcytosis (Casadevall 2010, Johnston and May 
2013, Eisenmann et al 2007, Chang et al 2004).  
 
1.4 The treatment of cryptococcal infections  
Treatment of cryptococcosis depends upon various factors that are dependent on the 
patient’s specific circumstances (Perfect et al., 2010). Recent guidelines suggest that 
for patients with a HIV co-infection, or other immunosuppressive conditions, a 
combinational drug approach should be taken, similar to that of the combinational 
therapy used in the treatment of tuberculosis (Perfect et al., 2010).  An induction 
therapy of amphotericin B and flucytosine is then followed by a consolidation therapy 
with fluconazole. Therapy can up to 12 months, but this is dependent upon the 
patients’ personal circumstances (Perfect et al., 2010). Amphotericin B is known to 
interact with fungal ergosterol and is believed to introduce pores into the fungal cell 
membrane, although this mechanism of action had been disputed (Ghannoum and 
Rice 1999). Flucytosine is a pro-drug and requires being taken up by susceptible 
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fungal cells (Vermes et al., 2000). Once deaminated into 5-fluorouracil (5-FU), the 
nucleotide analogue 5-fluorouracil triphosphate (5-FUTP) is incorporated into fungal 
RNA in the place of uracil and inhibits protein synthesis (Vermes et al., 2000). One 
metabolite of 5-FU also inhibits thymine production halting DNA synthesis as well 
(Vermes et al., 2000). Fluconazole, along with other azoles, are believed to affect 
ergosterol production in fungi, by inhibiting the heme-protein responsible for the 
demethylation of ergosterol precursors (Ghannoum and Rice 1999). In C. 
neoformans it has also been found that fluconazole inhibits reduction of 
obtusifolinone. This lack of ergosterol and variation in other related sterols leads to a 
loss in membrane stability and changing the overall membrane structure (Ghannoum 
and Rice 1999). Drug resistance has not been a major problem, but relapse during 
maintenance therapy has been shown to be due to fluconazole resistance in the 
cryptococci. This resistance has been associated with a disomy of chromosome 1, 
containing the ERG11 gene (Sionov et al 2010, Sionov et al 2013). Resistance to 
amphotericin B is associated with melanin production, possibly depositing it in the 
cell wall away from the membrane (Ikeda et al 2003). 
1.5 Virulence factors 
1.5.1 Melanin  
Melanin-like pigments are used by many organisms as protective compounds; in 
humans it is involved in protecting the skin from ultraviolet radiation, while in 
cryptococci it is known to factor into virulence (Casadevall et al., 2000, Ikeda et al., 
2003).  In C. neoformans melanin has been shown to be produced in vivo and has 
association with a resistance to immune function, as well as melanised cells being 
found in human brain tissue, giving possible reasoning for C. neoformans 
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neurotropism (Williamson et al., 1998, Steenbergen and Casadevall, 2003). Melanin 
is produced by the cell wall associated laccase enzyme and requires exogenous 
substrate such as the catecholamines (dopamine), unlike other fungi that can 
produce these pigments without external substrate (Steenbergen and Casadevall, 
2003). Melanised cryptococci show reduced susceptibility to oxidative stress and 
antimicrobial peptides produced by alveolar macrophages (Doering et al., 1999, 
Ikeda et al., 2003). Melanin is also implicated in a resistance to antifungal agents, 
such as amphotericin B (Wang et al., 1994). It has been suggested that the laccase 
enzyme, required for the polymerization of melanin, may be involved in reduction of 
hydroxyl free radicals, employed by alveolar macrophages in oxidative bursts 
(Williamson et al 1998, Casadevall et al 2000, Steenbergen and Casadevall 2003).  
1.5.2 The cryptococcal polysaccharide capsule  
The capsule of C. neoformans has been shown to be one of the most important 
virulence factors for the pathogen and as such it has been researched extensively. It 
is composed of glucuronoxylomannan (GXM), galactoxylomannan, and dispersed 
with mannoproteins. Deletion of one of the 4 capsular genes CAP10, CAP59, CAP60 
and CAP64, leads to abolishment of capsular production and abolition of virulence in 
the murine model (Kwon-Chung 1998, Steenbergen and Casadevall 2003, O’Meara 
and Alspaugh 2012). In vitro, the diameter of the capsule is relatively modest (4-8um) 
but upon infection this capsule increases in diameter. This has led to the conclusion 
that the capsule is required in vivo for virulence, the fact that unencapsulated strains 
of C. neoformans are avirulent proves this (O’Meara and Alspaugh 2012). The 
capsule prevents phagocytosis by preventing recognition of fungal cell wall 
components by phagocytic receptors, such as dectin-1 receptor and mannose 
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receptor, whose ligands (beta-glucans and mannose respectively) are found on the 
fungal cell wall (Johnston and May 2013). Once the fungi have crossed the BBB, 
GXM found in the cerebrospinal fluid has been associated with increasing cranial 
pressure, by disturbing water balance, leading to the tell tale symptoms such as 
blurred vision and headaches associated with fungal meningitis (Eisenmann et al., 
2007). 
1.6 Phospholipase B and its role in Cryptococcal virulence. 
Phospholipase B is part of a large family of phospholipases that are found 
ubiquitously, and function from initiators of lipid signalling to virulence factors for 
pathogens, such as Pseudomonas aeruginosa and Candida albicans (Ghannoum 
2000, Steenbergen and Casadevall 2003). Phospholipases act upon 
glycerolphospholipids, and have distinct activities. The phospholipase B enzyme is 
characterised by hydrolase activity against the sn-1 and sn-2 linkages found on 
glycerolphospholipids, the main component of plasma membranes (phospholipase A 
and lysophospholipase) (figure 3A) (Chen et al., 1997, Cox et al., 2001, Jones et al., 
2007). While C. neoformans Plb (CnPlb) maintains this characterised activity, a third 
activity is observed, lysophospholipase transacylase (LPTA) (Chen et al., 1997, Cox 
et al., 2001). Whereby the enzyme can catalyse the acylation of free fatty acids to 
lysophospholipids, allowing PLB to degrade and build phospholipids (figure 3A) 
(Chen et al., 1997, Cox et al., 2001). While it has been suggested that Plb1 contains 
2 active sites that facilitate the wide range of activities it possesses, Jones et al., 
2007 showed that CnPlb1 contains one active site with in a single domain (PLAC2) 
that can accommodate all three activities, possibly due to the loss of an occluding 
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cap region involved in substrate specificity in the catalytically similar phospholipase 
A2, found in C. albicans (Jones et al., 2007) (figure 3b).  
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Figure 3. A schematic diagram of C. neoformans Phospholipase B activity. 
A) Phospholipase B has three activities. Its first activity is its phospholipase A1 
activity where one on the fatty acid chains is cleaved from the phospholipid at the 
ester linkage (sn1/2) to the glycerol backbone to form a lysophospholipid. This 
lysophospholipid can then have the remaining fatty acid chain cleaved at the sn-2 
ester linkage by the Plb1 lysophospholipase activity (phospholipase A2). A third 
activity has been characterised, in C. neoformans phospholipase, 
lysophospholipase transacylase (LPTA). The LPTA activity of Plb1 catalyses the 
acylation of free fatty acids, to lysophospholipids.  
B) The domain diagram of C. neoformans phospholipase B. The region found 
between amino acid 1-19 contains a signal sequence required for its transport 
and subsequent lipidation. The PLA2c domain of Plb1 is responsible for all 3 
activities that Plb1 has been attributed to it, phospholipase A, lysophospholipase 
and lysophospholipase transacylase and is found between aspartate 46 and 
asparagine 572.  
Phospholipase B has recently been implicated in the virulence of certain fungal 
pathogens, such as Candida albicans and C. neoformans. In C. neoformans Plb1 
has been implicated in host survival, adhesion to the host, dissemination across the 
BBB, tissue invasion, lipid metabolism within the host, and maintaining membrane 
stability and cell wall integrity in the fungi (Ganendren et al., 2006, Siafakas et al 
2007, Wright et al 2007, Cheyakulkeeree et al., 2011, Maruvada et al., 2012). Plb1 is 
sequestered to the cell wall by a glycosylphosphatidylinositol anchor and this anchor 
is required for its secretion through the Sec pathway via the phosphatidylinositol 
transfer protein Sec14-1 (Djordevic et al., 2005, Siafakis et al., 2007, 
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Cheyakulkeeree et al., 2011). Knockout strains of Sec14-1 are not deleterious to C. 
neoformans, unlike other fungi; they do show a decreased virulence that is similar to 
the Plb1 knockouts and also lack extracellular phospholipase B activity 
(Cheyakulkeeree et al., 2011). In strains shown to produce larger amounts of 
extracellular phospholipase activity the converse is seen, showing increased 
virulence and quicker mortality in the murine model of infection, pointing toward an 
extracellular function of Plb1 being responsible for virulence in vivo. CnPlb has been 
shown to be covalently bound to the β-1,6-linked glucans of the cell wall, and release 
of CnPlb1 is mediated by β-1,6 glucanases encoded by C. neoformans (Siafakas et 
al., 2007). At increased temperatures Plb1 activity increases and the amount of Plb1 
associated with the cell wall also increases (Siafakas et al 2007).  
Knockout studies on Plb1 show a decrease in virulence associated with an increase 
in clearance by the macrophage, reduced vomocytosis, and a decrease in 
dissemination to the brain in the mouse model (Cheyakulkeeree et al., 2011). This 
has led to speculation that exported CnPlb is involved in survival within the 
macrophage, possibly due to degradation of the host phagolysosomal membrane, or 
by providing lipids to the cryptococcal cells for metabolism (Wright et al., 2007). Plb1 
knockout strains have been associated with a decrease in cell wall integrity, showing 
a lower capability to withstand stresses from detergents, such as SDS, that disrupt 
the membrane and interfere with protein folding (Siafakas et al., 2007). CnPlb has 
been shown to have a high affinity for dipalmitoyl phosphatidylcholine, a constituent 
of lung surfactant (involved in alveolar maintenance), phosphoglycerolipids, involved 
in preventing injury and infection in the lungs, and dioleoyl phosphatidylcholine, a 
component of macrophage membranes. (Griese 1999, Wright et al., 2007). C. 
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neoformans Plb1 has been associated with utilisation of host lipids. A report by 
Wright et al., 2007 showed that Plb1 is required for metabolism of radiolabelled host 
macrophage lipids, these fatty acids are then utilised in eicosanoid production, which 
is associated with melanin production. Plb1 was also implicated in subverting the 
macrophages’ response to C. neoformans, by utilising macrophage derived 
arachidonate, which is involved in activation of antimicrobial killing mechanisms in 
the macrophage, such as nitric oxide production (Ryoyama et al., 1993).  
Recent data (unpublished) from collaborators appears to show that a GFP tagged 
CnPLB1 is sequestered to the membrane, and localises at foci that could be lipids 
rafts, which Plb1 has been suggested to localize within (Siafakas et al., 2006). As 
well as localising in foci across the cell membrane, the tagged Plb1 appears to 
localise at the site of budding, possibly implicating Plb1 in cell division.  
1.7 Titan cells and their role in pathogenesis. 
One of the striking features about Cryptococcal infection is the increase in cell size of 
a sub-population of fungal cells during infection (Okagaki et al., 2010, Okagaki and 
Nielsen, 2012). Normally, C. neoformans has a diameter of 4-8um, but 24 hours after 
the initial infection event roughly 10-20% of cells have been found to reach up to 900 
times larger in volume than normal (figure 4) (Zaragoza et al., 2010). While C. 
neoformans has been shown to increase the size of the polysaccharide capsule 
during infection, so called titans cells have tell tale traits that differentiates them from 
C. neoformans cells with increased capsule thickness (figure 4). They exhibit a highly 
cross linked polysaccharide capsule, which is both resistant to DMSO treatment and 
γ-radiation, both of which strip the capsule off of normal sized cells grown in vitro 
(Zaragoza et al., 2010). To add to this the cell wall of the cells increases in thickness 
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from 50-100nm to 2-3um. The appearances of vesicles that stain with the vacuole 
specific marker MDY-64 have been seen in titan cells, either as a single large vesicle 
or many small ones (Zaragoza et al., 2010). Titan cell have also been shown to have 
an increase in nuclear content, roughly reaching around 16 times the amount of DNA 
found in cells grown in vitro, while other studies have found this to range from 4-64 
polyploidy (Zaragoza et al., 2010). This increase in DNA content has been suggested 
to be required for the maintenance of the modified cell wall found in titan cells 
(Zaragoza et al., 2010). These characteristics of an increased cell size and polyploidy 
have been associated with defects in cell cycle, causing endoreduplication in 
Sacchromyces cerevisae (Okagaki et al., 2011). In C. neoformans titan cells produce 
normal sized and presumptively haploid offspring (Okagaki and Nielsen, 2012).  
The production of titan cells have been shown to increase virulence in the mouse 
infection model, with mice infected with FACS purified titan cells showing a higher 
fungal burden when compared to the wild-type (Crabtree et al., 2012). As well as this, 
C. neoformans strains that have titan cell production knocked out show decreased 
virulence and mortality in the mouse model, when compared to the wild-type strains 
(Okagaki and Nielsen, 2012). Virulence is restored in the knockout cells when they 
are reconstituted with gpr4/gpr5 receptors (Okagaki and Nielsen, 2012).  Titan cells 
have been implicated in promoting early pulmonary survival as well as increasing 
dissemination to the CNS and inhibiting phagocytosis of normal size cells (Zaragoza 
et al., 2010, Okagaki and Nielsen, 2012). This protection against phagocytosis is not 
solely due to the size of the titan cells conferring resistance, as latex beads of a 
similar size to titan cells, 30 µm, do not provide a protection to phagocytosis of 
normal sized C. neoformans. This immunomodulatory function against the host 
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immune system is linked with the large vesicular compartments seen in titan cells 
that have been shown to contain immunomodulatory compounds that affect 
phagocyte function and may be responsible for this protective affect (Oliviera et al 
2010, Okagaki and Nielsen, 2012). 
While there is no conclusive evidence as to how titan cells form, formation has been 
shown to require specific cellular signalling. Two receptors found on the cryptococcal 
surface, GPR5 and Ste3a, modulate titan cell formation, both acting on the 
PKA/cAMP pathways (which controls other C. neoformans virulence factors), and 
activate the transcription factor, RIM101. RIM101 homologues play important roles in 
virulence in pathogenic fungi (Okagaki et al 2011, Okagaki and Nielsen 2012, 
Zaragoza and Nielsen 2013). While the ligand for GPR5 has not been discovered, 
Ste3a, the pheromone receptor, has been shown to enhance titan cell formation in 
the less virulent MATa sex, with up to 40% of cells being of titan cell morphology in 
co-infections with both cryptococcal mating types (Okagaki et al 2011).  Although 
other receptors have not been ruled out in affecting the production of titan cells, the 
two discussed receptors, in particular GPR5, play important roles (Okagaki and 
Nielsen 2012, Okagaki et al 2011).  
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1.8 Project aims  
Previous studies within the group have shown that cell diameter, and therefore cell 
size, increases in Plb1 knockout cells, when phagocytosed by J774.1 macrophages. 
These cells do not appear to reach the same size as titan cells do in vivo, but they 
may be precursors of titan cells. To study whether these large cells are the beginning 
Figure 4. An India Ink stained imaged of cryptococci from an infected mouse 
lung. 
As the image shows it can be seen that the ‘giant cells’ (another term for titan cell) 
(circled red), are massive when compared to other ‘regular’ cryptococci (circled 
blue) and have a large increase in polysaccharide capsule which does not stain 
with India Ink.   
Figure reproduced from Zaragoza, 2011.  
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of titan cell formation, we intended to use the known markers of titan cells, cell size 
and nuclear content, to study this distinct morphology. From this we would hopefully 
be able to determine whether these cells carry markers for titan cells and implicate 
Plb1 in titan cell formation and fungal cell morphology. 
2. Materials and Methods 
2.1 Strains, media and cultivation 
During the study C. neoformans var. grubii strains H99, ΔPlb1, ΔPlb1:Plb1 
reconstituted, referenced as PLB1rec, were used. Both mutant strains came from a 
H99 parent, and produced through methods described by Cox et al., 2001. C. 
neoformans stocks were stored at -80°C, thawed and streaked onto yeast 
extract/peptone/D-glucose (YPD) agar (1% yeast extract, 2% peptone and 2% D-
glucose) and incubated at 25oC for 48 hours. Plates were then stored at 4oC until 
required.  Overnight cultures of 2mL YPD broth were seeded with colonies picked 
from the stored YPD plates, incubated at 25°c and rotated 25 rpm. J774.1 
macrophage cells were used throughout the experiment; cells were cultured in 
Dulbecco’s Modified Eagle’s Media (DMEM), which had been supplemented with 
10% (50mL) live foetal bovine serum (FBS), 1% (5mL, 2mM) 200mM L-glutamine 
and 1% (5mL) 10,000 units penicillin/ 10 mg streptomycin. J774.1’s were maintained 
in an incubator at 37°C in 5% CO2 during the study. 
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2.2 Freezing down and thawing of J774 macrophage stocks.  
2.2.1 Freezing  
Media for freezing down stocks of J774 cells consisted of 50% FBS, 40% complete 
DMEM and 10% dimethyl sulfoxide (DMSO). This was filter sterilised (0.2µm) to 
remove possible contaminants. 8 flasks of confluent J774 cells were scraped into 
fresh complete DMEM. The cells were spun at 1000xg for 7 minutes to sediment 
cells. The supernatant was discarded, and cells resuspended in the freezing media 
(5ml for every flask). The suspension was aliquoted into 1mL cryovials, frozen at -
80°C for 24 hours, and then moved into liquid nitrogen for prolonged storage. 
2.2.2 Thawing of J774.1 cells 
Once removed from liquid nitrogen storage, cells were defrosted in a water bath at 
37oC. Once defrosted, the 1mL aliquots were added to 9mL complete DMEM and 
centrifuged at 1000xg for 7 minutes. Pellets were resuspended in 15mL of DMEM 
and incubated in T75 culture flasks overnight at 37oC. 24 hours after thawing DMEM 
was replaced with fresh media, or passaged if needed.  
2.3 Preparation of coverslips 
Coverslips were treated with 20mL of nitric acid, and left for 10 minutes at room 
temperature. Nitric acid was poured off and coverslips dowsed in dH2O. Coverslips 
were then washed with dH2O three times. Ethanol was used to wash the coverslips a 
further 2 times, and then coverslips stored in ethanol at room temperature until 
needed.  
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2.3.1 Immunostaining of coverslips 
Prepared coverslips were removed from the ethanol and allowed to dry for 30 
minutes. Dried coverslips were incubated in 200µL 0.1% (w/v) Poly-L-lysine (PLL) 
(Sigma Aldrich) for 1 hour at room temperature. Coverslips were then washed with 
dH2O to remove non-bound poly-L-lysine. Aliquots of the GXM specific monoclonal 
antibody 18B7 (kindly provided by Arturo Casadevall) were diluted 1 in 5000 and 15 
µL pipetted on to parafilm. Poly-L-lysine treated coverslips were placed poly-L-lysine 
treated side down, in contact with the 15µL of 18B7. The coverslips were then 
incubated at room temperature for 1 hour. After incubation PLL-18B7 treated 
coverslips were washed 3 times in dH2O, covered in phosphate buffered saline (PBS) 
and stored at 4oC.  
2.4 Infection of J774.1 macrophages with C. neoformans 
2.4.1 Preparation of C. neoformans for infection 
One day prior to infection, overnight cultures of C. neoformans strains H99, ΔPLB1, 
PLB1rec, were cultured as previously described (2.1). On the day of infection 
overnight cultures were vortexed to ensure the cells were evenly suspended and 
1mL of culture was removed from each culture tube. The 1mL samples were spun at 
8000xg for 3 minutes. The supernatant was discarded and pellets resuspended in 
1mL PBS. This was repeated 3 times and C. neoformans cells resuspended in a final 
volume of 1mL of PBS. 1 in 10 dilutions of C. neoformans cells were counted on a 
haemocytometer and dilutions of 1x106/100µL were made. C. neoformans cells were 
then opsonised with 0.1uL/100µL of 18B7 monoclonal antibodies, and incubated at 
room temperature for an hour on a rotator.  
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2.4.2 Macrophage preparation  
 Macrophages were also prepared on the day prior to the infection. J774.1 cells were 
scraped from a confluent flask and the number of cells was counted with a 
haemocytometer. J774.1 cells were then diluted to 1x105cells/mL into complete 
DMEM. 1mL of the diluted culture was used to seed wells of a 24 well plate (each 
well was seeded with 1x105 cells) and incubated overnight at 37oC, 5% CO2. 
133ng/mL of phorbol-12-myristate-13-acetate (PMA) was used to activate J774.1 
cells via the PKC pathway, increasing the phagocytic activity. Complete DMEM was 
removed from J774.1 cells plated the previous day, and replaced with 1mL of serum-
free DMEM (SF-DMEM) and 15µL of the 10µg/L PMA dilution. The cells were 
incubated at 37oC for 45 minutes and the SF-DMEM removed and replaced with 1mL 
SF-DMEM.  
2.4.3 Infection of J774.1 macrophages 
J774.1 cells were infected C. neoformans at a multiplicity of infection (MOI) of 10 and 
incubated for 2 hours at 37oC, 5% CO2 to allow for phagocytosis. After 2 hours, 
media was removed from each well, and then washed and agitated 3 times with 1ml 
PBS to remove PMA and non-phagocytosed C. neoformans. After the washes 1mL 
of SF-DMEM was added and cells incubated for a further 18 hours.  
2.4.4 Fixation of C. neoformans cells  
0 hour wells were washed and then the macrophages were lysed with 200µL dH2O 
for 20 minutes. C. neoformans cells and J774.1 debris was scraped off the plate 
bottom and aliquoted into microcentrifuge tubes. Wells were washed with 200µL PBS 
and aliquoted into the 200µL dH2O. C. neoformans cells were centrifuged at 8000xg 
for 3 minutes, the supernatant was discarded and cells were resuspended in 400µL 
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paraformaldehyde (PFA) to fix the cells. Cells were incubated for 10 minutes in PFA 
and then washed 3 times in 400µL PBS, centrifuging at 8000xg for 3 minutes in 
between washes. Cells were finally resuspended in 400µL PBS. At the 18 hour time 
point, cells were treated in the same manner and fixed as described previously. If 
cells were not imaged on the day of fixing they were stored at 4oC until imaging. 
2.4.5 Preparation of slides for imaging 
For initial imaging, 15µL of sample was pipetted onto a glass slide and a coverslip 
placed on top. When using immunostained coverslips, fixed lysates were pipetted 
onto the immunostained side of the coverslip and centrifuged at 1000xg for 10 
minutes and incubated for 1 hour. When lysates have not been fixed, samples are 
placed upon the immunostained coverslip and centrifuged as before. After 
centrifugation, lysates are fixed to the coverslip with 400µL PFA and incubated for 15 
minutes before washing with PBS.   
2.4.6 Clumping of macrophage debris 
To remove macrophage debris from the lysate 0.1% PLL was added to the lysate, to 
increase clumping. Lysates were placed upon immunostained coverslips and were 
fixed and treated as before (2.4.5).  
2.5 Preparation of macrophage lysate 
Non-activated macrophage lysate (referred as essence of macrophage (EoM) in 
results) was collected as so. J774.1 cells were scraped from a confluent culture in 
10mL SF-DMEM. For activated macrophage lysate J774.1 cells were activated with 
SF-DMEM supplemented 133ng/mL PMA in the culture flasks for 45 minutes prior to 
lysis. Cells were lysed through sonication, with 15 seconds pulsing and 15 seconds 
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rest, for 2 minutes or until all cells were lysed, which ever was the longest (cells 
never took greater than a total of 4 minutes to lyse through sonication). During 
sonication cells were kept on ice to prevent the lysate becoming excessively hot.  
2.5.1 Measuring cell growth in macrophage lysate 
Once lysed, the macrophage lysate was plated on a 24 well plate, 1mL per well and 
inoculated with 5x105 C. neoformans. As a control SF-DMEM was inoculated with 
5X105 C. neoformans cells. Lysate experiments were carried out with H99, ΔPLB1 
and PLB1rec strains over a 7 day period. Where by, every 24 hours cells would be 
resuspended and a dilution of the suspension would be removed and plated onto 
YPD agar and incubated for 48 hours at 25oC. After the incubation, colonies were 
counted and colony-forming units (CFU) per 0.5µL calculated. 
2.6 Staining of the Cryptococcal cells  
To visualise the nucleic acids of cryptococcal cells during the project, both Hoechst 
33342 and 4',6-diamidino-2-phenylindole (DAPI) fluorescent stains were used. Both 
Hoechst and DAPI bind preferentially bind A-T rich sequences in double stranded 
DNA. Once cells had been fixed, they were stained with 0.5 µg/ml of Hoechst 33342 
and incubated at room temperature for 30 minutes. After incubation cells were spun 
at 17000xg for 0.5-5 minutes, depending on the amount of macrophage debris then 
washed with 400µL of PBS to remove unbound dye. This process was repeated 2-3 
times depending on the amount of cells recovered after the infection. Cells were 
finally re-suspended in 200µL of PBS. 
400µL of C. neoformans cells, from infections or washed overnight cultures, were 
added onto the coverslip and centrifuged at 500xg for 5 minutes to force the C. 
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neoformans cells to contact the surface of the coverslip. Coverslips were incubated 
at room temperature for 15 minutes. Supernatants were discarded, taking care not to 
disturb the coverslips and cells were fixed to the coverslip with 4% PFA at room 
temperature for 10 minutes, and then washed 3 times in PBS. 
2.7 Imaging of Cryptococcal cells and measuring of cell diameter 
All microscopy was undertaken on a Nikon Eclipse Ti microscope, mounted with a 
QImaging QICAM-B mono camera. All images, brightfield and fluorescent, were 
viewed through a Nikon Plan APO VC 60x Oil DIC N2 objective lens. All images of 
Hoechst fluorescence were imaged with an exposure time of 700ms, while all 
Brightfield images were given a 70ms exposure time.   
Cell sizes were measured using the ‘circle drawing’ function on Nikon NIS Element 
Advanced research imaging software. The software was able to determine the 
diameter of cells due to a function whereby each pixel is representative of a set 
length. All images were taken on the 60x lens and each pixel measured was 0.11µm.  
2.8 Measuring cell growth and cell size under nutrient deficient conditions 
To determine whether nutrient deficiency affected the proportion of ΔPLB1 cells that 
grew beyond 8µm, 24 well plates were set up with a decreasing concentration of 
YPD broth, diluted out with PBS to a final volume of 1mL, ranging 100% YPD, 50% 
YPD, 25% YPD, 12.5% YPD and 1% YPD. Wells were then inoculated with 100µL of 
a 1 in 10 dilution from overnight cultures, prepared in the same manner as 2.4.1. 
Stains tested were H99, ΔPLB1, and PLB1rec, they were incubated at 37oC for 48 
hours and the optical density at 600nm was measured every 30 minutes.  
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2.9 Data analysis of Cryptococcal cell diameter 
For each condition, the diameter of up to 100 cells was measured. To check whether 
the cell diameter distribution had significantly changed over the course of the 
experiment a non-parametric Mann-Whitney U test was performed to compare the 
means of each condition. The z-values, an output of the significance, were calculated 
using an online tool (http://elegans.som.vcu.edu/~leon/stats/utest.cgi). Due to the α-
value being 0.05, significant results would found with Z value outside of -1.95 to 1.95. 
2.10 Flow cytometry of Cryptococcal cells after infection 
To test for an increase in cell size after infection in the Plb1 mutant C. neoformans 
cells H99, ΔPLB1 and PLB1rec were used in an infection assay (same protocol as 
stated in section 2.4). After the 18-hour infection, lysates were stained with Hoechst 
33342 as previously. Controls consisted of Hoechst 33342 stained non-infected 
macrophage debris that had been treated in the exact manner infected macrophage, 
pre-infection C. neoformans (all 3 strains) and non-stained C. neoformans post-
infection H99. Samples were measured for forward scatter and fluorescence on a BD 
biosciences FACS Aria II cell sorter. Flow cytometry data was analysed using FlowJo 
flow cytometry analysis software (TreeStar Inc).  
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3. Results 
3.1 Staining of the nuclear content of macrophage incubated cryptococci to 
observe whether larger cells were polyploidy 
3.1.1After fixing and washing, cryptococcal cells recovered from macrophages 
were limited and often co-localized with macrophage debris  
To semi-quantitatively determine the nuclear content of cryptococcal cells after 
infecting and incubating within mouse macrophages we attempted to extract the 
fungal cells and stain specifically for the nucleic acids. This would allow us to semi-
quantitatively determine whether Plb1 knockout cells have an increased amount of 
nucleic acids, a titan cell marker. To image the nuclei of C. neoformans cells after 
infection, macrophages were lysed in water. This was to allow for the imaging of the 
fungal nuclei without interference from the stained macrophage nuclei. The lysates 
were fixed with PFA and washed 3 times in PBS. Lysates were stained with 
0.5µg/mL Hoechst 33342. When cells were imaged, it was apparent that C. 
neoformans cells were sparse on the coverslip, and were found to co-localize with 
macrophage debris (figure 5). The macrophage debris stained strongly with the 
Hoechst 33342 and made analysing the nuclei of cryptococci impossible (figure 5). 
This was seen with all 3 strains at 0 hours and 18 hours post infection. As well as co-
localizing with the macrophage debris, a large amount of background fluorescence 
was observed. Suggesting that nuclear material, lysed from macrophages, was also 
binding with Hoechst 33342 in the lysate.  
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Figure 5: Co-localization of C. neoformans cells with J774 macrophage debris 
after lysis.  
To study the nuclear content of C. neoformans cells after J774 macrophages were 
lysed 18 hours after being infected with an MOI of 10 of C. neoformans. The lysate 
was then stained with 0.5µg/mL of Hoechst 33342. Cells were imaged with 
QImaging QICAM-B mono camera attached to a Nikon Ti eclipse microscope, 
viewed on a Plan APO VC 60x Oil DIC N2 objective lens. Figure 5A shows the 
Brightfield image. Figure 5B shows the same imaged when fluoresced under UV 
light to excite the Hoechst 33342 stain. As it shows fungal cells localize with J774.1 
debris, making imaging of the nucleus impossible. 
A	  
B	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3.1.2 The addition of poly-L-lysine to the lysate improved the amount of cells 
per coverslip but fungal cells co-localized with debris 
In an attempt to improve the yield of fungal cells found on the coverslip, coverslips 
were treated with poly-L-lysine (PLL) and immunostained with the GXM specific 
monoclonal antibody, 18B7. This would hopefully help reduce the loss of cells on the 
coverslip to washing, due to fungal cells directly binding to the monoclonal antibody. 
18B7 immunostained coverslips showed an improvement in the amount of fungal 
cells visible. Unfortunately, as with the untreated coverslips, cryptococci co-localized 
with macrophage debris, leading to analysis the size of the cryptococci nuclei 
impossible, similar to figure 5 (data not shown).  
Because Matsui et al., 1983, showed that PLL acts as a non-physiological opsonin, 
and may have been a factor causing macrophage debris binding to the PLL treated 
coverslips, PLL was added to the lysate during washing to clump the macrophage 
debris together. Hopefully, preventing its dispersion across the coverslip. Imaging 
showed that macrophage debris had clumped together (Figure 6), but macrophage 
debris was bound to the C. neoformans cells (Figure 7). This prevented analysis of 
the size of the C. neoformans nuclei. This was found in all strains at 0 hours and 18 
hours post infection. DAPI infused vector shield was found not to penetrate 
cryptococcal cells, but did stain nuclear material in the lysate (data not shown). 
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Figure 6: Using Poly-L-Lysine to clump together J774 macrophage debris. 
To try and prevent J774.1 macrophage debris from interfering with analysis of C. 
neoformans nuclear content, 0.1% poly-L-lysine was added to the lysate prior to 
imaging. Images were taken with QImaging QICAM-B mono camera attached to a 
Nikon Ti eclipse microscope, viewed on a Plan APO VC 60x Oil DIC N2 objective 
lens. Figure 6A is the brightfield image of debris, 6B Hoechst stained nuclear 
content and 6C is the composite image. The addition of PLL to the lysate helps 
clump the debris together.  
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Figure 7: Using Poly-L-Lysine to clump together J774 macrophage debris 
causes macrophage debris to bind to fungal cells. 
To try and prevent J774.1 macrophage debris from interfering with analysis of C. 
neoformans nuclear content 0.1% Poly-L-Lysine was added to the lysate prior to 
imaging. Images were taken with QImaging QICAM-B mono camera attached to 
a Nikon Ti eclipse microscope. Figure 7A is the Brightfield image of debris, 7B is 
the imaged when excited with UV light to image the nuclear content and 7C is the 
composite image. The addition of PLL to the lysate clumps macrophage debris 
together but also causes debris to bind to the fungal cells. This prevents any sort 
of reliable imaging of C. neoformans nuclei.  
Cryptococcal	  cell	  
with	  bound	  debris	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3.2 Does macrophage lysate induce an altered phenotype in Plb1 knockout C. 
neoformans? 
3.2.1 Plb1 knockout cells did not show a change in cell diameter after a 7 day 
incubation in SF-DMEM or macrophage lysate  
During this portion of the study we chose to investigate the cell diameter, and 
therefore cell size (another known marker of titan cell), of Plb1 knockout cells due to 
the difficulties of measuring nuclear content, as described previously. Every 24 
hours, during the experiment, cultures in SF-DMEM and macrophage lysate were 
sampled and imaged under the microscope. Cell diameter, cell morphology and 
relative growth (measured in colony forming units) were measured over a 7 day 
period. All C. neoformans strains were incubated in SF-DMEM and EoM. Cell 
diameter was measured and plotted onto box whisker plots (Figure 8). H99 showed 
significant decrease in cell diameter between the day 0 measurement and day 7 
measurements (Z=5.09, P<0.001). A significant decrease in cell diameter was also 
observed between the start point and day 7 measurement of the H99 strain in EoM 
(z=7.1818, P<0.001). Unfortunately, at the 6/7-day stage the H99 in the EoM 
appeared to lyse in the culture, limiting the amount of cells countable on those days 
(Figure 9). Neither of the ΔPLB1 conditions, in SF-DMEM or EoM showed a 
significant difference in cell diameter after 7 days incubation (z=0.603, P>=0.05 and 
z=0.765, P>=0.05, respectively). The diameter of PLB1rec cells in SF-DMEM also 
decreased significantly over the incubation (z=6.98, P<0.001). Similarly, a significant 
decrease in cell diameter was also seen in the PLB1rec cells that had been incubated 
in EoM (z=9.42, P<0.001). The PLB1rec cells incubated in EoM, began to lyse after 6-
7 days, the same as the H99 (Figure 9). These results suggest that it is not a 
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component of the macrophage lysate that induces large cells. What is interesting to 
note is that when the wild-type H99 and reconstituted PLB1rec strains were incubated 
in EoM they both appeared to begin to lyse at days 6 and 7, while ΔPLB1 cells did 
not. This would suggest that EoM affects the wild type and reconstituted strains, 
during prolonged incubation. While the ΔPLB1 knockout has a protective effect. 
ΔPLB1 cells at 10 days did not begin to show the lysed phenotype, suggesting that it 
is not related to the speed of growth between the wild type and mutant. 
3.2.2 Over 7 days of incubation in macrophage lysate a significant number of 
Plb1 knockout cells were shown to have an altered cell morphologies 
During the course of the incubation it was noted that certain cells appeared to have 
morphology very distant from the ‘normal’ round morphology of C. neoformans. 
These cells appeared to have projections stemming from the surface, taking on an 
appearance similar to that of pseudohyphae (Figure 10). To measure this, 100 fungal 
cells were counted and the amount of cells with this phenotype was recorded. As 
shown in figure 11, this morphological phenotype appeared more so in the cells 
incubated at 37oC in EoM. In the EoM, the ΔPLB1 strain showed a greatest amount 
of fungal cells with this morphology than any other strain, with the greatest amount 
being seen on day 5. The ΔPLB1 mutant in SF-DMEM and the H99 in EoM appear to 
have similar amounts of cells with this morphology. H99 cells in SF-DMEM showed 
only 1 cell with this morphology over the whole 7 day incubation (N=2). On days 2 
(P<0.05, 0.0022), 5 (P<0.05, 0.0035), 6 (P<0.05, 0.0061) and 7 (P<0.05, 0.012) there 
was a significant increase in cells with an altered morphology in the population of 
Plb1 knockout cells gown in macrophage lysate when compared to wild type cells 
grown in the same media. A significant difference was not seen between the 
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morphologies the H99 strain and Plb1 knockout when incubated in SF-DMEM.  
These results indicate that the knockout of Plb1 affects cell morphology in cells 
incubated in macrophage lysate when compared to the wild type strain.  
3.2.3 Attempts at trying to determine whether the absence of extracellular Plb1 
was responsible for the altered cell morphology in the Plb1 knockout strain 
were unsuccessful 
To observe whether the effect of Plb1 on cell morphology was due to internal or 
secreted phospholipase activity, a H99/ΔPLB1 co-infection was attempted. 
Transwells were used to ‘house’ the H99 cells while ΔPLB1 cells were outside the 
transwell on the plate base. The transwell would allow for the diffusion of Plb1 across 
the membrane. Even though this proved promising, after 2 days contamination was 
found in all conditions and proved to bring an end to this avenue of investigation.   
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Figure 8: Box and whisker plots C. neoformans cell diameter over 7 days 
incubation in SF-DMEM and J774 macrophage lysate.  
Every day during of the lysate experiment the diameter of 100 fungal was 
measured for each strain and range and distribution plotted. All 3 strains were 
incubated in SF-DMEM as a control and J774 macrophage lysate (EoM). The 
whiskers of the boxes represent the range of the diameters. While the centre line 
of the box represents the mean and upper and lower lines of the box represent 
the upper and lower interquartile ranges respectively.  Between day 0 and day 7 
of incubation a significant decrease in cell diameter was found in H99 cells 
incubated in SF-DMEM and macrophage essence (EoM) (Z=5.09, P<0.001 and 
Z=7.1818, P<0.001, respectively). A significant decrease in cell diameter was 
also seen in the Plb1 reconstituted cells when grown in SF-DMEM (Z=6.98, 
P<0.001) and macrophage essence (EoM) (Z=9.42, P<0.001), after 7 days in 
incubation. Plb1 knockout cells did not show a significant change in cell diameter 
over the 7-day incubation.  
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Figure 9: After 7 days incubation in J774 macrophage lysate H99 cells and 
Plb1reccells appear stressed.  
Images were taken with QImaging QICAM-B mono camera attached to a Nikon Ti 
eclipse microscope, viewed on a Plan APO VC 60x Oil DIC N2 objective lens. 
During the incubation in the macrophage lysate H99 and PLB1rec appeared to 
stress and lyse at the 7 day period. The image is a brightfield image of PLB1rec 
cells on day 7 of incubation. 
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Figure 10: During incubation in macrophage lysate ΔPlb1 cells had different 
morphologies.  
Images were taken with QImaging QICAM-B mono camera attached to a Nikon Ti 
eclipse microscope, viewed on a Plan APO VC 60x Oil DIC N2 objective lens. 
During the incubation in the macrophage lysate ΔPLB1 cell morphology changed 
with what appears to be projections coming from some cells. These appear to be 
similar to pseudohyphae, as described by others.  
Cells	  with	  projections	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Figure 8 
  
Figure 11: The proportion of fungal cells, out of 100 counted, with altered 
cell morphology, similar to psuedohyphae, observed during incubation of 
H99 and Plb1 knockout strains in macrophage lysate and SF-DMEM.  
The number of cells with projections coming away from the C. neoformans cells 
were counted every day (per every 100 cells) and plotted. While all strain in all 
media showed this altered morphology during the incubation, ΔPLB1 cells 
showed a greater amount of cells with this altered morphology in macrophage 
lysate, than any other condition.  On day 2 (P<0.05, 0.0022), 5 (P<0.05, 0.0035), 
6 (P<0.05, 0.0061) and 7 (P<0.05, 0.012) the amount of cells with an altered 
morphology was significantly different in the Plb1 knockout cells when compared 
to H99 cells grown in macrophage essence.  A significant difference was not 
seen when comparing Plb1 against the H99 wild type when grown in SF-DMEM 
at any day. 
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3.2.4 Plb1 knockout cells do not survive as well as wild type/reconstituted 
Cryptococci in SF-DMEM and essence of macrophage 
Do determine whether the ability to survive in stress inducing conditions was different 
in the Plb1 knockout strain, cell viability was measured in SF-DMEM and 
macrophage lysate over 7 days using colony forming units (CFU). CFUs were 
measured daily by plating out a dilution of the culture onto YPD plates and incubating 
for 48 hours at 25oC. After this, colonies were counted and CFUs/0.5µL calculated. In 
all three conditions the ΔPLB1 mutant fared worse than the H99 and PLB1rec strains, 
as shown in figure 12 but only Plb1 cells grown in SF-DMEM showing a significant 
difference comparative to the wild type and Plb1rec strains at days 4 (P<0.05, 0.042), 
5 (P<0.05, 0.023) and 7 (P<0.05, 0.026). Strains incubated in EoM showed a similar 
pattern with ΔPLB1 faring worse than the other two strains. But in EoM, ΔPLB1 fared 
better in CFU count, at day 7, of 2632 CFUs/0.5uL averaged over 2 repeats. While 
both the H99 and PLB1rec had CFUs of 4616 and 5816 respectively at day 7 but this 
found not to be statistically significant when compared to the wild type and Plb1 
reconstituted strains. Plb1 knockout cells fared better in EoM than those in SF-
DMEM, which is expected, as macrophage lysate would contain potential metabolites 
for C. neoformans. Although, it is unknown how long these may last in the lysate 
before degrading. This is in confliction with microscopy observations, where at day 7 
both the H99 and PLB1rec strains appeared fewer in numbers, with many cells being 
stressed and immeasurable. This could be due to the cells observed under the 
microscope being less tolerant to the protocol used to fix the cells. Or, it could 
suggest that the lysed cells observed before were not dead, and were indeed viable. 
Even though the ΔPlb1 strain was slightly less viable in YPD all three strains fared 
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similarly over the course of the experiment with no significant difference between 
CFU counts (figure 12).  
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Figure 9 
 
Figure 12: Cell viability and growth as measured by colony forming units 
per 0.5µL of culture (CFUs/0.5µL) during the macrophage lysate 
experiment.  
Everyday, growth and viability was measured by counting colonies on YPD agar 
plates after dilution of the cultures were plated out. Plates were incubated at 
25oC for 48 hours. CFUs were measured for C. neoformans grown in SF-DMEM, 
EoM and YPD broth. Across all 3 conditions the ΔPLB1 strain fared worse than 
every other strain, although in EoM and YPD this was not found to be 
significantly different to the wild type or reconstituted strain. In SF-DMEM the 
Plb1 mutant had significantly fewer colonies on days 4 (P<0.05, 0.042), 5 
(P<0.05, 0.023) and 7 (P<0.05, 0.026) when compared to the H99 strain.  
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3.3 Measuring cell growth and cell size in nutrient deficient conditions to 
investigate whether nutrient deficiency induces the large cell phenotype  
3.3.1 There is no increase in cell diameter in C. neoformans cells over 48 hours 
of nutrient deficiency 
To determine whether nutrient deficiency, specifically, was the cause of the increase 
in cell diameter, H99 and ΔPLB1 cells were incubated for 48 hours at 37oC in 
gradually decreasing amounts of YPD. After the incubation cells were imaged as 
previous, and the diameters of 100 cells were measured and plotted. Growth of each 
strain in each condition was measured by optical density at 600nm (OD600) every 30 
minutes. In this experiment cell diameter was measured twice, while growth at OD600 
was measured once. Cells grown in 100% YPD reached an average maximum OD of 
0.130 and 0.1394, for H99 and ΔPLB1 respectively (Figure 13). Surprisingly, cells in 
both 50% and 25% YPD grew better than their counterparts in 100% YPD (Figure 
13). H99 cells grown at 50% YPD reached a maximum OD600 of 1.603, the ΔPlb1 
cells grew to 1.696, and H99 and ΔPLB1 cells grown at 25% YPD attained an OD600 
of 1.643 and 1.703. C. neoformans cells grown in 12.5% YPD were only marginally 
worse reaching an average peak OD of 1.25 and 1.144, in the H99 and ΔPLB1 
respectively (Figure 13). Both H99 and ΔPLB1 cells performed worse in 1% YPD, as 
expected, most probably due to the very limited amount of nutrients available to them 
for active growth and proliferation.  
As well as the growth curve data, cell diameter was measured before and 48 hours 
after incubation, for each condition. There was a significant decrease in cell diameter 
between the C. neoformans H99 at 0 hours and at 1% YPD (z=1356, P<0.001) 
(Figure 14). There was also a significant decrease in cell size for C. neoformans H99 
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grown in 12.5% (z=14.038, P<0.001) (Figure 14). In ΔPLB1 the same trend was seen 
with cells grown in 1% YPD significantly decreasing in diameter over the 48 hours 
(z=10.17, P<0.001), but different to the H99 there was no significant difference 
between 0 hours and 12.5% after 48 hours (Figure 14). While in the PLB1 mutant 
there was a significant increase in cell diameter between the 0 hour and 100% YPD 
after 48 hours (z=8.953, P<0.001), which seems odd as cells were grown in 100% 
prior to inoculating the conditions so no change would be expected (Figure 14).   
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Figure 13: Growth curves of C. neoformans subjected to varying amounts 
of nutrient starvation during incubation at 37OC for 48 hours.  
To look at how nutrient starvation affected growth of cells C. neoformans cells 
were grown in decreasing amounts of YPD broth to mimic nutrient starvation. 
Growth was measured every 30 minutes and determined by optical density at 
600nm (OD600). Cells grown in 100%, 50% and 25% YPD appeared to have no 
detrimental effects on growth over 48 hours in both strains. While in 12.5% and 
1% YPD both strains appear to growth less than the 100% YPD counterpart. 
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Figure 14: Cell diameter of C. neoformans in varying degrees of nutrient 
starvation after 48 hours of incubation at 37oC 
To determine whether nutrient deficiency may cause the increase in cell diameter 
during infection or causes the altered morphology, C. neoformans H99 and ΔPLB1 
were incubated in lower concentrations of YPD for 48 hours to mimic nutrient 
starvation.  The whiskers of the boxes represent the range of the diameters. While the 
centre line of the box represents the mean and upper and lower lines of the box 
represent the upper and lower interquartile ranges respectively.  In the H99 strain, 
comparative to the cell diameter of 0 hour cells those grown in 12.5% YPD and 1% 
YPD (z=13.56, P<0.001 and z=14.038, P<0.001, respectively). Plb1 mutants showed a 
significant decrease in cell diameter over 48 hours when grown in 1% YPD (z=10.17, 
P<0.001), but oddly show a significant increase in cell diameter when grown in 100% 
YPD (z=8.953, P<0.001).  
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3.4 Using flow cytometry to measure the fluorescence of nuclear content in 
cryptococcal cells after macrophage incubation  
3.4.1 After 18 hours of infection within J774 macrophages there is an increase 
in the proportion of cells with a greater diameter and more nuclear material in 
the ΔPLB1 strain 
Flow cytometry was employed to differentiate between cell size and nuclear content 
of C. neoformans cells, pre-infection and 18 hours post infection. This was chosen as 
a quicker, more precise method at measuring both of these parameters, which had 
been difficult to do under the microscope. Forward scatter (FSC) would measure 
fungal cell size, while the fluorescence, due to DNA binding stain Hoechst 33342, 
would be measured as a semi-quantitative measurement of the amount of nuclear 
material in each cell. The results from the flow cytometry data were gated against the 
fluorescence of the macrophage debris to remove this debris from the results 
(Supplementary figure 1). Unstained post-infection H99 cells were used as controls, 
proving that fluorescence was solely due to Hoechst 33342 staining and not auto-
fluorescent (Figure S2). As shown in figure 15, all populations of pre-infection cells 
were similarly sized and had similar nuclear content. What is interesting is that there 
appeared to be sub-populations within the sample. This could be attributed to cells, 
which are undergoing budding or in different phases of cell cycle (Figure 15). 
After 18 hours within the macrophages C. neoformans cells were lysed with dH2O. 
Post infection, all 3 strains showed an overall increase in forward scatter, indicating 
an increase in cell size. To determine whether cells were getting larger post-infection 
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a gate was placed on cells with a forward scatter of 400 or above. A forward scatter 
of 400 was chosen as the cut off for larger cells, because in all 3 strains tested 99% 
of the population was found to be below a forward scatter of 400. A gate based on 
the fluorescence was also applied to the data. The gate was applied on particles 
which fluoresced greater than 103. This gate was chosen due to less than 2% of 
cells, in all strains, having fluoresced above this point prior to infection. All 3 strains 
after the 18-hour infection showed an increase in the population above the 400 FSC 
unit gate. 7.99% of H99 cells reached over the 400 FSC unit gate, while ΔPLB1 cells 
and PLB1rec cells had 19.7% and 4.25% of cells above 400 FSC units, respectively. 
After 18 hours of infection the proportion of cells with nuclear fluorescence above 103 
increases, indicating an increase in nuclear content. Both H99 and PLB1rec cells have 
17.7% and 16.4% of the population above 103, while in ΔPLB1 cells 50.5% of cells 
have nuclear content above 103. When both gates are placed on top of each other, 
the percentage of cells with a FSC above 400 and fluorescence greater than 103 is 
different between all three strains. 5.17% of H99 cells, 3.86% of Plbrec and 17.8% of 
ΔPlb1 cells showed greater size and nuclear fluorescence (figure 15).  While it is not 
quantitative, the data does show that knocking out Plb1 affects nuclear content 
during infection along with an increase in cells size. Although this is not conclusive 
proof that these are titan cells, it is interesting that as the cells increase in size so 
does the nuclear content, which is a known marker of the titan cell morphology.  
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Figure 15: Cryptococcal cell size and nuclear content measured by 
forward scatter (FSC-A) and Hoechst fluorescence, before and after 18 
hours incubation in J774 macrophages.  
Flow cytometry was employed to determine cell size and nuclear content of 
H99, ΔPLB1 and PLB1rec cells after infecting J774 macrophages for 18 hours. 
Samples were stained with 0.5µg/ml Hoechst 33342 after fixing. Plots were 
gated on stained macrophage debris to remove the majority of macrophage 
debris from the infected samples. While all strains increase in both size and 
nuclear content, there is a greater amount of cells, which are above these 
gates in the ΔPLB1 mutant (17.8% in the ΔPLB1 strain when compared to the 
5.17% in H99 and 3.86 % in Plbrec.) 
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4.0 Discussion 
Even though imaging of cryptococcal nuclear content, to semi quantitatively 
determine overall nuclear content, was not achieved during the study, we were able 
to observe an increase in overall nuclear content through flow cytometry with the use 
of DNA-specific fluorescent stains. This experiment leads to possible suggestion that 
in the Plb1 knockout cells that have been recovered from infection of macrophages 
have an increase in both cell size and nuclear content, both markers of titan cells. 
While this is not conclusive it proposes a new route of investigation to answer this 
question. As well as the observation of increased nuclear content, Plb1 knockout 
cells showed altered cell morphology, similar to clinically relevant pseudohyphae, 
when grown for 7 days in macrophage lysate. 
4.1 Hoechst staining of C. neoformans cells after infecting into macrophages 
The first obstacle during the investigation was the lack of observable cells in 10uL of 
fixed, post infection, lysate on coverslips. This could be attributed to the relatively few 
cells up taken by macrophages, even after opsonisation, described previously to be 
as low as 10%. As well as the relatively low amount of particle uptake, the process of 
centrifugation, washing and re-suspending the lysate pellets (to remove SF-DMEM 
and PFA after infection and fixation) will compound the loss of cells in the samples. 
The few cells that were observable upon microscopy were mostly co-localized with 
macrophage debris, which meant analysis of the fungal nuclei impossible.  To try and 
combat this various methods were employed. Firstly, coverslips were treated with 
poly-L-lysine (PLL) and immunostained with the mouse IgG1 antibody, 18B7, to bind 
fungal cells directly to the coverslip. 18B7 has a variable region that binds 
specifically, and with high affinity, to glucuronoxylomannan found in cryptococcal 
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polysaccharide capsule (Casadevall et al. 1998). Coverslips were treated with PLL 
and then incubated with 18B7 to allow for binding of the MAb to the poly-L-lysine 
matrix. The lysates were placed on top of coverslips and centrifuged to force the C. 
neoformans cells upon the coverslips, where they would hopefully bind specifically 
with PLL-bound 18B7. Coverslips were then fixed to secure the binding between the 
antibodies and there ligand on the Cryptococcal cell surface.  While this did work and 
many more C. neoformans cells were visible during imaging, the same problem was 
observed, colocalization of C. neoformans with macrophage debris. To try and 
separate C. neoformans from debris, the lysates were vortexed vigorously for 5 
minutes. Then lysates were centrifuged, to attempt to pellet C. neoformans without 
pelleting macrophage debris. This proved unfruitful as debris and fungal cells 
pelleted at the same time, likely due to them both being of similar size after lysis. 
One reason for the increased amount of debris binding to the immunostained 
coverslips could be due to macrophage debris binding the poly-l-lysine on the 
coverslip. Poly-L-lysine has been shown to act as non-physiological opsonins, and 
Matsui et al., 1983, claim this to be due to non-specific ionic interactions, due to poly-
l-lysine’s charge. Whether this still occurs once cells have been lysed is debatable, 
but this offers a possible reason why macrophage debris appeared bound to the 
coverslip, which should be specifically binding GXM in the Cryptococcal capsule.  
Another method of preventing dispersed clumping was treating the lysate with poly-L-
lysine prior to fixing, to clump the macrophage debris together. This proved effective 
in clumping debris together and allowing more cells to disperse across the coverslip. 
But unfortunately it seemed that small portions of macrophage debris bound to the 
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surface of the cryptococcal cells making the whole cell fluoresce, it also appeared to 
make the capsule partially visible (Figure 7).  
One possible way to get round this excess fluorescence would be to treat the lysate 
with a low concentration of DNAse to remove background fluorescence. Although 
caution would have to be taken to not affect the nuclear material in C. neoformans 
cells. To determine this, one could undertake an experiment where the concentration 
of DNAse required to effect C. neoformans nuclear material, prior to infection, is 
determined. Then the use of a concentration of DNAse lower than determined 
amount could be applied to the lysates to remove background fluorescence without 
effecting fungal cells.   
Vector shield infused DAPI unfortunately failed to stain cryptococci under normal 
conditions, but did stain the macrophage debris in the fixed lysate. While it is 
disappointing, this could be attributed to the DAPI vector shield being out of date. 
This would be interesting to use in future studies.  
4.2 Macrophage lysate incubations 
While the enlarged cell morphology was not observed in the SF-DMEM or 
macrophage lysate in any of the strains examined, all strains showed altered cell 
morphologies after prolonged incubation in the macrophage lysate. After 6-7 days 
both the H99 and PLB1rec cells appeared stressed in the lysate and looked like they 
may be lysing (Figure 9), but this was not observed in ΔPLB1 cells incubated in 
macrophage lysate, nor in strains incubated in SF-DMEM. To look at whether this 
persistence was due to a slower growth of ΔPLB1 cells, they were observed after 10 
days of incubation, and ΔPlb1 cells did not have the same stressed morphology as 
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H99 cells in EoM. This suggests that the knockout of ΔPLB1 may have a beneficial 
effect when incubating in macrophage lysate. While this is interesting, cell viability 
was not measured directly, and it is unknown whether these cells apparently lysing 
cells were dead or viable. Viability could be tested directly with trypan blue exclusion, 
which has been used previously to check cryptococcal cell viability (Byrnes III et al., 
2010).  
To indirectly measure cell viability CFUs were measured every day during the 
incubation. This appeared to show that on day 7, CFUs reached their highest levels 
for almost all strains in all conditions, which would suggest that these stressed cells 
are still viable. During the measurement of cell diameter it was surprising to observe 
that ΔPLB1 knockout cells, in macrophage lysate predominantly, had with projections 
jutting from the surface that do not appear to be buds (Figure 10). These cells appear 
to be similar to previously described pseudohyphae (Lee et al., 2012). 
Pseudohyphae have been observed in human lung tissue, and when incubated in the 
presence of amoeba. The pseudohyphal morphology has been associated with a 
survival strategy for host survival and escape (Bava et al., 2008, Gazzoni et al., 
2010, Lee et al., 2012). What is interesting to see is that this morphology is 
regulated, along with other factors implicated in host survival (like titan cells), via the 
cAMP/PKA pathway. Nutrient starvation, specifically limited ammonium, has been 
shown to influence a reversible switch between normal and pseudohyphal 
morphologies (Lee et al., 2012). Even though these cells appear to look similar to 
pseudohyphal cells, the fact that ΔPLB1 cells have irregular cell shapes during 
incubation, such as ovoid cells, shrouds doubt that these may be true pseudohyphal 
cells. This is especially true when GFP-tagged Plb1 appears to localise near buds 
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(unpublished data). But if these are indeed pseudohyphae it is interesting that they 
are seen when incubated in macrophage lysate. This could possibly indicate that 
there may be compounds within macrophages that induce this morphology, and that 
Plb1 is involved in regulating this.  
4.3 Nutrient starvation 
To observe whether any of the phenotypes described were due to nutrient starvation, 
cells were grown in decreasing amounts of YPD broth for 48 hours. The cell diameter 
was measured before and after the incubation, and optical density at 600nm was 
measured during the incubation to observe the growth. From the 100% YPD to 1% 
YPD the mean cell diameter decreases. This can be attributed to cells dividing but 
then not increasing in size, as they get older due to the lack of nutrients available. As 
well as the decrease in mean cell diameter, no larger cells (above 8µm) were 
observed after 48 hours in any condition, nor were any cells with altered morphology 
i.e., pseudohyphae, were seen. This suggests that nutrient starvation is not the 
cause of the increase in cell size or change in morphology in the ΔPLB1 strains, but 
rather an influence of the macrophage itself (with the case of larger cells) or by 
something produced by them (in pseudohyphae-like cells). 
4.4 Flow cytometry 
Due to the large amount of background fluorescence, as well as co-localisation of C. 
neoformans cells with macrophage debris, flow cytometry was employed to measure 
amount nuclear fluorescence against the cell size measure by the forward scatter 
(FSC). A cut off for cells larger than a FSC of 400 units was chosen. This was due to 
less than 1% of cells reaching this size in all three strains, before infection. To begin 
with, post 18 hours infection, in all three strains the proportion of cells above the 400 
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FSC threshold increases. A greater proportion of cells above the 400 FSC thresholds 
are found in the Plb1 mutant. This suggests that there is an effect could be due to the 
Plb1 deficiency, causing cell size to increase during its residency in the macrophage, 
once phagocytosed. To determine whether this increase was due to the possible 
formation of titan cells, we chose to look at the nuclear content as well. This is due to 
previous studies showing that titan cells produced in vivo had increase nuclear 
content, with cells becoming polyploidy (Okagaki et al., 2011). If this is the case for 
the Plb1 mutants there should be an increase in fluorescence. To determine this, 
populations observed through the flow cytometry were gated on the amount of 
fluorescence due to Hoechst staining. In pre-infection populations 98% of cells 
fluoresced below 103, this was then used as a gate and cells, which fluoresced more 
than this, are assumed to have more than ‘normal’ nuclear content. While all 
populations showed an increase in cells above this threshold, with H99 and PLB1rec 
having populations 17.7% and 16.4% of the population, the ΔPLB1 population had a 
dramatic increase with 50.5% of the population being above 103. It would be 
interesting to carry this out in human PMBC to see if a similar phenomenon would be 
observed. 
If this increase in nuclear content were due to polyploidy, there would be distinctive 
clustering of cells in the flow cytometry data. One reason for the increased DNA 
content could be increasing portions of DNA during stressful conditions. Sionov et al., 
show that during treatment of C. neoformans with azoles a disomy of chromosome 1 
occurs leading to resistance to the drug, due to duplication of the target of 
fluconazole and duplication of the exporter of fluconazole. This ability form a disomy 
of chromosomes may be a reaction to stressful conditions, such as those found in the 
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macrophage, which may also explain why you see an increase in nuclear content in 
the H99 and reconstituted strains. But this doesn’t explain why there is a dramatic 
increase in Plb1 knockouts. Giant cells in other fungi, such as Saccharomyces 
cerevisae, occur through endoreduplication. Endoreduplication is where there is an 
absent M phase during cell cycle and the genome is duplicated. Budding does not 
occur, leading too larger than normal cells that are also polyploidy. This has been 
suggested to involve the Pcl1 homologue in C. neoformans, where it interacts with 
cell cycle regulators like the C. neoformans cdc42/cdc42, as well as being involved in 
localization of neck bud protein Bni4 during budding (Okagaki et al., 2011), where by 
a down regulation of Pcl103 in C. neoformans may lead to less budding and 
endoreduplication, forming titan cells. While this is a mechanism by which titan cells 
may form, it is still unclear where Plb1 functions in the formation. After receiving the 
image that showed GFP tagged Plb1 localizing near budding sites, one could ponder 
whether Plb1 is involved in budding and disruption of its activity may lead to 
disrupted cell division under stressful conditions. This may be the cause of the 
altered morphologies seen in the macrophage lysate, where Plb1 mutants appeared 
to be deficient in budding and produced ovoid cells, as well as cells which appear to 
have never completed budding.   
5.0 Conclusions 
While these results cannot be used to definitively answer whether phospholipase B is 
involved in the regulation of titan cell formation. It is interesting to note that, upon 
deletion of Plb1, cell size of the cryptococci changes after infection, when compared 
to that of the H99 parental strain. To add to this, the fact that these larger cells would 
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appear to have an increased amount of nuclear content, as shown through flow 
cytometry data, teases with the possibility of these may be related to titan cells. But, 
this phenotype of could not be replicated in media that has been supplement with 
macrophage lysate which has been shown to be able to induce titan cells in other 
studies, suggests that this phenotype in the Plb1 mutant requires phagocytosis of the 
fungi. Even though the questions proposed at the beginning of the study have not 
been conclusively answered, this information may help in deciphering the 
mechanistic route required for the increase in fungal cell size.  
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6.0 Supplementary figures   
6.1 Supplementary figure 1 
 
	  
Supplementary figure 1: The flow cytometry plot of uninfected 
macrophage debris.  
All post infection plots were gated on this, to remove most of the 
macrophage debris from the 18 hour sample. Uninfected macrophages 
were incubated for 18 hours, washed and lysed following the same 
protocol as those, which were infected with C. neoformans.  
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6.2 Supplementary figure 2 
	  
  
Supplementary figure 2: Unstained C. neoformans H99 18 hours 
after infection. 
Due to the slim possibility of autofluorescence C. neoformans H99 were 
incubated and lysed in the same manner as all other post infections but 
were not stained with Hoechst 33342 after lysis from the macrophages. 
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7.0 Introduction  
Bdellovibrio bacteriovorus is a Gram negative bacterium of the δ-proteobacterium 
class (Sockett 2009). Most notable about the species is its predatory lifestyle, 
whereby it preys upon other Gram-negative bacterium, notably pathogenic species 
like Escherichia coli and Salmonella enterica (Sockett 2009, Atterbury et al., 2011 
Dwidar et al., 2012). B. bacteriovorus is found ubiquitously throughout the 
environment from soil to sea to the mammalian intestine (Schwudke et al., 2011, 
Hobley 2005, Sockett 2009, Iebba et al., 2013). Its highly motile nature allows it to 
move through these environments in search for prey, other Gram negative bacterium 
(Lambert et al., 2006, Lambert et al., 2011). It goes about this by the use of both 
gliding and flagella motility on/through solid and liquid environments, respectively 
(Lambert et al., 2006, Lambert et al., 2011). Gliding motility, in particular, has been 
implicated in the predation and escape from prey on solid surfaces (Lambert et al., 
2011, Hobley et al., 2012). This predation, in turn, has been shown to be dependent 
on cyclic-di-guanosine monophosphate (C-di-GMP) signalling (Hobley et al., 2012). 
C-di-GMP signalling has known roles in decision making in bacterial lifestyles, the 
mechanisms of how this decision making occurs or how predation of the prey is 
initiated remains to be understood (Krasteva et al., 2012). In view of this, this study 
will attempt to shine some light on the mediators of C-di-GMP signalling in B. 
bacteriovorus, through the techniques of protein biochemistry and crystallography. 
Hopefully deciphering the roles of the lipid binding protein (Bd2538), von willebrand 
domain protein (Bd1483) and suspected GYF-PilZ domain proteins (Bd1996 and 
Bd3100) in Bdellovibrio prey recognition and C-di-GMP signalling that lead to prey 
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invasion. This information will then useful in producing a hypothesis for this important 
part of the Bdellovibrio lifecycle.   
7.1 Possible uses of Bdellovibrio spp. 
The discovery of Bdellovibrio in the early sixties led to a great interest in this 
interesting predatory bacterium, leading to the coined ‘golden age’, which has since 
led to a slowing down of research, albeit a few dedicated individuals. (Stolp and 
Petzold, 1962, Stolp and Starr, 1963, Sockett et al., 2004, Sockett 2009) Recently, 
there has been a great resurgence in interest with the bacterium with the emergence 
of multidrug resistant bacteria, leading to the discussion as to whether Bdellovibrio 
could be the first ‘living antibiotic’. Due to resistance to predation being rarely seen in 
E. coli prey, and then only transient (Sockett 2009, Dwidar et al., 2011, Lerner et al., 
2012 Kadouri et al., 2013).  
Although there have been a few limitations noted; these include an optimal 
temperature for growth of 29°C, and its apparent aerobic way of life (Varon and Shilo, 
1968, Sockett 2009, Atterbury et al., 2011). Both of these have shown not to be a 
great of a hurdle, as Bdellovibrio have been isolated from the faeces of humans 
overcoming the high temperatures and anaerobic environment found in the gut 
(although Bdellovibrio have developed ways to respire anaerobically, such is the 
environment inside the bdelloplast) (Sockett et al., 2004, Atterbury et al., 2011Iebba 
et al., 2013). As well as this, its safety has been brought into question due to similar 
predatory α-proteobacterium that have been shown to invade mitochondria of 
parasitic ticks, and if the presence of Bdellovibrio will have negative effects on the 
microbiota of the gut or induce an inflammatory response in humans (Rendulic et al., 
2004, Sacchi et al., 2004). While experiments on the effects of Bdellovibrio treatment 
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directly on mammalian hosts have not been undertaken, Atterbury et al., 2011 
undertook a study using chickens as a surrogate. Salmonella fed chickens showed 
reduced levels of Salmonella in the gut and faeces after Bdellovibrio introduction. 
Chickens that were not fed Salmonella were also treated with Bdellovibrio, while the 
overall gut microbiota changed after 2 days there were no adverse health effects 
(Atterbury et al., 2011). To add to the evidence that Bdellovibrio do not harm hosts, 
by changing the overall gut microbiota, a study by Iebba et al., 2013, showed a 
relationship between the absence of Bdellovibrio in the intestine of patients with 
inflammatory bowel disease and celiac disease. While this is not conclusive these 
studies provide tantalizing prospects that the use of Bdellovibrio as a therapeutic 
probiotic may treat a variety of digestive diseases.  
7.2 The lifecycle of host dependent B. bacteriovorus 
B. bacteriovorus tracks down its prey through chemotactic responses to amino acids 
and biofilms (with B. bacteriovorus HD100 containing 20 genes required for 
chemotaxis) (LaMarre et al., 1977, Sockett 2009). It was previously believed that 
Bdellovibrio entered prey by ‘punching’ themselves into prey via their fast flagella 
motility, this has been disproven with flagella motility mutants still being able to 
predate, if placed upon their prey (Sockett, 2009). Bdellovibrio attachment, to prey, 
occurs from the non-flagella pole of the bacterium (figure 1), with this attachment 
being shown to be transient and reversible (Rendulic et al., 2004, Sockett, 2009).  
While it is unknown what mediates attachment, but through fluorescently tagged 
microscopy proteins have been shown to localize at the non-flagella pole. These 
include proteins involved in C-di-GMP signalling that are known to be up regulated 
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and secreted during attachment (figure 1) (Hobley et al., 2012, Capeness et al., 
2013, Milner et al., 2014).  
Once attached to the prey cell, Bdellovibrio must enter and pass through the outer 
membrane (figure 2). It has now been discovered that a cocktail of degradative 
enzymes are required (Milner et al., 2014).  Although the mechanism of attachment 
has not been fully discovered, it has been shown that type IV pili play a major role in 
this attachment. Similar to some pathogenic bacteria, that use type IV pili to attach to 
the host structures. Type IV pili retractable fibre knockouts were shown to be unable 
to predate upon fluorescently tagged prey, even when placed a top of them (Craig et 
al., 2004, Evans et al., 2007, Hobley, et al., 2012, Milner et al., 2014).  
Invasion across the outer membrane takes 2 minutes to complete, and occurs 
through a pore that is smaller to the diameter of invading Bdellovibrio (Sockett 2009). 
The formation of the initial localised pore still remains uncharacterised, as does how 
Bdellovibrio reseals the hole once it has entered the periplasmic space. Entry has 
been suggested to occur through secreted twitching pili that attach to the 
peptidoglycan of the prey cell and provide an anchorage point to drag the 
Bdellovibrio into the prey, and then the flagellum is shed (figure 2) (Rendulic et al., 
2004, Evans et al., 2007, Lerner et al., 2012). As Bdellovibrio begins to break down 
the host macromolecules it begins expression of membrane transporters that are 
believed to be involved in the import of prey nutrients into the predatory cell (Beck et 
al., 2004, Rendulic et al., 2004). While inside the bdelloplast, Bdellovibrio begin 
secretion of a multitude of hydrolytic enzymes required for prey degradation (Lerner 
et al., 2012). Of these, certain transpeptidases have been shown to be involved in 
prey rounding. Bd3459 and Bd0816 are ‘penicillin binding protein 4’ (PBP4) like DD-
	  75	  
	  
endo/carboxytranspeptidase, which are often used in maintenance of cell shape and 
division. Upon invasion, both of these proteins are up regulated and are involved in 
prey rounding, by breaking the peptide bridges that link the strands of peptidoglycan 
(PG) together, loosening the PG (Lerner et al., 2012). These proteins have also been 
implicated in the preventing ‘tailgating’ Bdellovibrio from entering the invaded cell. 
This was suggested to be due to the softening of the PG, removing a sturdy 
anchorage point for other Bdellovibrio to invade cell (Lerner et al., 2012).  
As the Bdellovibrio resides in the bdelloplast it begins to replicate its DNA using host 
components (Sockett, 2009). But, the genome of prey is, more often than not, 
insufficient to provide the amount of nucleotides required for the progeny (Sockett, 
2009). This means that nitrogen-containing macromolecules must be catabolised for 
the production of nucleotides (Rosson and Rittenburg 1981, Sockett 2009). 
Replication occurs without septation, initially, forming a long filamentous cell in the 
bdelloplast. Once resources have been exhausted in the predated cell the long 
filamentous cell undergoes septation, which leads to odd and even numbers of 
Bdellovibrio progeny (figure 2). When the progeny have septated, flagella motility is 
induced and a burst of hydrolytic enzymes degrade the rest of the PG shell and the 
progeny swim away in attack phase looking for their next prey (Rendulic et al., 2004). 
This whole process from invasion to escape takes around 4 hours (Sockett, 2009) 
(figure 2).  
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7.2.1 Host independent strains 
Gene deletions within certain amino acid synthesis pathways have been discovered 
lending more credence to Bdellovibrio’s obligate predatory lifestyle (Rendulic et al., 
2004, Sockett 2009).  But host independent strains (HI) have been cultured on 
extremely nutrient rich peptone-yeast (PY) media, which provide the bacterium with 
the nutrients it cannot synthesise itself (Rendulic et al., 2004, Sockett 2009). One 
strain has been shown to live both predatory and anexically (host independent). 
Termed Tiberius, due to its discovery from the River Tiber, Italy, this strain has 
acquired host independency that is distinct from the more common mutations in 
proteins from the hit locus, namely bd0108 (bdt0101 in Tiberius), which are observed 
Figure 1.  Cartoon structure of a Bdellovibrio bacteriovorus cell. 
A cartoon structure of a Bdellovibrio bacteriovorus cell, noting the anterior biting tip 
where recognition and penetration of prey occurs and secretion of and localisation 
C-di-GMP signalling proteins localise. At the posterior end the single flagellum 
required for locomotion, is depicted 
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in a laboratory setting (Cotter and Thomashow, 1992, Rendulic et al., 2004, Hobley 
et al., 2012a, Capeness et al., 2013). Proteins in the hit locus have been shown to be 
involved in pilus regulation, with knockouts of bd0108 lacking pili (Rendulic et al., 
2004, Capeness et al., 2013). Mutations in this locus occur in 89% of lab HI strains 
(Capeness et al., 2013). This ability to live predatory and anexically has been 
attributed to the high levels of organic pollutants, faecal waste, and rich variety of 
prey bacteria in the river (Hobley et al., 2012a). As well as the rich environment from 
which it came from, this host independent phenotype has been linked to lateral gene 
transfer from ‘sub-optimal’ prey, such as marine bacterium, which are found in the 
river Tiber, along with its standard laboratory prey E. coli and S. enterica (Hobley et 
al., 2012a).  
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Figure 2. The lifecycle of host dependent Bdellovibrio bacteriovorus.  
A) Attachment to the prey cell (Red) by attack phase B. bacteriovorus (Blue). B) 
Invasion into the periplasmic space due to pilus retraction. C) The release of 
hydrolytic enzymes modifies the host cell forming the bdelloplast. D) Replication 
occurs, forming a long filamentous Bdellovibrio that divides by septation. E) 
Flagella motility is induced and the progeny lyse the bdelloplast in attack phase 
searching for Gram negative prey.	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7.3 Cyclic di-GMP signalling  
7.3.1 A brief introduction 
First discovered as a regulator of cellulose synthase in Gluconacetobacter xylinus, 
cyclic di-guanosine monophosphate (C-di-GMP) has been shown to be an important 
signalling molecule for many bacterial species across many different bacterial 
lineages (Ross et al., 1987, Weinhouse et al., 1995, Romling et al., 2005, Amikan et 
al., 2006, Jenal and Malone, 2006). Production of C-di-GMP in bacteria is catalysed 
by a group of proteins known as diguanylate cyclases. Proteins of this class contain a 
GGDEF motif and, as with adenylate cyclases, dimerisation is required for fully 
functional activity (Romling et al., 2005, Romling and Amikan 2006). These GGDEF-
containing proteins are also under feedback inhibition with a conserved RxxD motif, 
termed ‘I sites’; these bind C-di-GMP and inhibit the formation of c-di-GMP (Jenal 
and Malone, 2005, Schirmer and Jenal, 2009, Krasteva et al., 2012, Hobley et al., 
2012). While no GGDEF containing proteins have been found in eukaryotic 
genomes, showing the lack of this signalling pathway, there remains receptors of this 
molecule, presumably used by the innate immune system as recognition of bacterial 
infection (Romling et al., 2005 Krasteva et al., 2012). Break down of C-di-GMP is 
carried out by phosphodiesterases containing EAL and HD-GYP domains. EAL 
domains are highly specific phosphodiesterases that require either Mg2+ or Mn2+ as 
cofactors (Schirmer and Jenal, 2009, Krasteva et al., 2012). These domains are 
understood to be regulated through accessory domains that catalyse the degradation 
of C-di-GMP to pGpG that can then be further degraded to GMP (Romling et al., 
2005, Schirmer and Jenal, 2009). The other motif involved in the degradation of C-di-
GMP is HD-GYP. Only recently a few HD-GYP domains have been structurally 
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deciphered, including an unconventional HD-GYP domain containing protein from B. 
bacteriovorus (Lovering et al., 2011, Bellini et al., 2014). These studies have shown 
that this HD-GYP is an iron binding protein as well as showing that bacterial HD-
GYFs can be grouped into two families of proteins with bi- or tri- nuclear metal 
binding centres (Lovering et al., 2011, Bellini et al., 2014).   
PilZ domain proteins were first observed in cellulose synthase from G. xylinus. PilZ 
domains follow a phylogenetically similar distribution to C-di-GMP metabolising 
enzymes (Weinhouse et al., 1995, Amikan and Galperin, 2006). PilZ binding domains 
are characterised by 6-antiparralell β barrel strands which contain conserved C-di-
GMP binding sequences, RxxxR and D/NxSxxG, located on the N termini of β2 and 
β3 respectively (Krasteva et al., 2012). While PilZ domains recognise C-di-GMP they 
have many different conformational reorganization upon binding of the nucleotide, as 
well as changing dimeric states (Krasteva et al., 2012). PilZ domain proteins have 
been shown to be required for type 4 pili (T4P) formation in P. aeruginosa, upon 
transition to a biofilm forming state. Also, they have been involved in changing 
motility states, C-di-GMP has been shown to influence gene regulation, often 
switching on/off genes required for lifestyle choices in bacteria such as V. cholera 
and P. aeruginosa (Schirmer and Jenal, 2009, Krasteva et al., 2012). They have also 
been observed in M. xanthus and are required for normal spore formation (Amikan 
and Galperin, 2006). Along with PilZ domains, degenerate GGDEF domain 
containing proteins have been implicated as receptors for C-di-GMP (Schirmer and 
Jenal, 2009, Hobley et al., 2012, Krasteva et al., 2012). Binding is due to the 
preservation if the C-di-GMP binding I site. These proteins have been implicated in 
signalling, biofilm formation and motility, of which their role in B. bacteriovorus will be 
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discussed later (Schirmer and Jenal, 2009, Hobley et al., 2012, Krasteva et al., 
2012). 
7.3.2 What is known of C-di-GMP signalling in B. bacteriovorus? 
As described previously, C-di-GMP signalling has been shown to be involved in 
changes of lifestyle for many bacteria and it is becoming apparent that this is the 
case for B. bacteriovorus as well. This can be inferred from a genomic context, as 
from its 3.8Mbp genome it has been shown to have a high C-di-GMP ‘intelligence’ 
(Hobley et al., 2012). Sequencing and bioinformatics data show 15 predicted PilZ 
domain containing proteins, including Bd3100 and Bd1996, are associated with C-di-
GMP signalling (Amikan and Galperin, 2006). B. bacteriovorus HD100 also contains 
5 GGDEF containing proteins, 4 of which are functional C-di-GMP producing 
enzymes and one with a degenerate GGDEF motif that has been shown to be a 
receptor for C-di-GMP signalling (Hobley et al., 2012). As far as ceasing the signal 
induced by C-di-GMP, B. bacteriovorus HD100 contains 7 phosphodiesterases, 1 
EAL and 6 HD-GYP proteins. An overall diagram for C-di-GMP signalling in B. 
bacteriovorus has been summarised in figure 3. 
Studies undertaken by Hobley et al., 2012 have shown that knocking out 4 of the five 
GGDEF domain proteins, termed DgcA-C (diguanylyl cyclase) and CdgA (the 
degenerate GGDEF domain with predicted receptor activity), produce visible 
phenotypes in B. bacteriovorus. They also show interesting phenotypes when over 
expressed in the highly motile E. coli strain, MG1655. The fifth GGDEF, DgcD, 
showed no phenotype when knocked out in B. bacteriovorus, nor when over 
expressed in E. coli (Hobley et al., 2012). This is interesting as this protein is not 
conserved in the Tiberius strain of B. bacteriovorus (Hobley et al., 2012). When over 
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expressed in E. coli MG1655, DgcA-C causes this highly motile strain to become 
sessile, presumably due to their production of C-di-GMP. This has been shown 
previously, with pathogenic strains of E. coli, to signal a transition to a sessile, 
biofilm-forming state, which is related to virulence. (Ryan et al., 2006, Hobley et al., 
2012, Hu et al 2013). When the degenerate GGDEF, CdgA, is over expressed a 
motile phenotype in E. coli is observed. Presumptively, this due to CdgA binding host 
C-di-GMP therefore acting as a sink for the signalling molecule (Hobley et al., 2012). 
In B. bacteriovorus the knockout of DgcA produces a phenotype that was immobile, 
similar to the ΔfliC mutant, and could predate prey bacteria if placed directly upon 
them but are unable to induce motility once the prey has become exhausted and end 
up stuck in the dead prey’s shell, even though the exit pore has been formed 
(Lambert et al., 2006, Hobley et al., 2012). This shows that DgcA is required for 
gliding motility in Bdellovibrio and has been suspected to interact with a PilZ domain 
containing protein, Bd1482, which is found in a gliding motility operon (figure 3) 
(Lambert 2011, Luciano et al., 2011, Hobley et al., 2012). DgcB, when knocked out in 
B. bacteriovorus, was shown to produce a phenotype that was non-predatory and 
could only be grown anexically. Although rare cases have been observed where a 
supressed predatory phenotype is observed, which will be important for research use 
(Hobley et al., 2012). This GGDEF domain is linked to a forkhead domain that is 
believed to be involved in the signalling and gets activated when DgcB begins to 
synthesis C-di-GMP, due to active site mutants not rescuing the mutant phenotype 
(figure 3) (Hobley et al., 2012). Forkhead domains are abundant in eukaryotes and 
have been associated with regulation of many bacterial processes from cell shape to 
signal transduction to host-bacterium interactions (Pallen et al., 2002). Due to this it 
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has been suggested that DgcB signals the cell to start production of hydrolytic 
enzymes, upon prey biting (Hobley et al., 2012). DgcB has also been implicated in 
the downstream signalling to CdgA (figure 3). ΔCdgA mutants were grown anexically 
but later shown to predate, albeit slowly, especially during prey entry (Hobley, et al., 
2012). CdgA was also shown to locate at the ‘biting’ anterior tip of the bacterium 
(figure 1). This, along with results from Milner et al., 2014 show that CdgA also 
associates gliding motility machinery proteins, RomR and MglA (figure 3). Both of 
which associate at the biting tip and are involved in gliding motility in M. xanthus, also 
MglA is required for prey invasion through type 4 pili (T4P) extrusion (Milner et al., 
2014).  
MglA and RomR, in M. xanthus, have been shown to regulate the leading tip for 
gliding motility via the Frz chemotactic response, but this Frz pathway is missing in 
Bdellovibrio (Milner et al., 2014). So, it is suggested that CdgA is the signal required 
for RomR and MglA to begin extrusion of the T4P required for prey invasion, this 
links C-di-GMP with prey invasion through T4P upon stimulation of prey biting as well 
as C-di-GMP involvement in prey escape, via gliding motility (Hobley, et al., 2012, 
Milner et al., 2014). MglA has also been associated with invasion through an 
interaction with a tetratricopeptide repeat (TPR) motif protein, Bd2492, as both 
knockouts prevent invasion but not attachment (Milner et al., 2014).  Adding weight to 
there proposed roles in T4P extrusion (Milner et al., 2014). The TPR repeat protein 
interacts with the TamAB transporter system, suggested to secrete proteases and 
other hydrolytic enzymes for prey invasion/digestion, as well as secretion of 
extracellular polysaccharides and polyelectrolytes both required for pilus retraction in 
M. xanthus (figure 3) (Milner et al., 2014). TamA is an Omp85 membrane pore that 
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has been associated with secretion of proteases, auto-transporters and adhesins in 
E. coli. TamB associates with the inner membrane and is co-purified with TamA in E. 
coli (Selkrig et al., 2012).  This shows a specific interconnectivity between C-di-GMP 
and its involvement in gliding motility (DgcA), secretion of hydrolytic (DgcB regulating 
expression of and its signalling to CdgA) and pilus retraction 
(CdgA/MglA/RomR/TamAB) (figure3).  
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Figure 3. A diagram of C-di-GMP signalling in Bdellovibrio bacteriovorus at 
the anterior pole. 
 Bd1483 (Blue pie), a protein with a vWA domain, is suggested to be involved in 
prey recognition either by interacting directly with the prey cell or involved in a 
mediator (black square) responding to the prey cell (brown circle). While it is 
known that Bd1483 is secreted it is unknown where it localises. So here it has 
been placed in the periplasm, extracellular milieu and associated with the inner 
and outer membrane. Signalling due to Bd1483 is predicted to be transmitted by 
an unknown membrane associated partner (white box), which transmit the signal 
to the cytoplasmic PilZ/DUF4339 domain proteins (Grey) (Bd1482, Bd1996 and 
Bd3100). These PilZ/DUF4339 proteins are, in turn, influenced by the cyclic-di-
GMP producing protein DgcA (light blue oval), with the DUF4339 domains 
interacting with downstream signalling proteins, possibly including the GGDEF 
proteins. C-di-GMP from DgcA is believed to regulate the gliding motility 
machinery. DgcA has also been shown to directly interact with CdgA (orange 
circle), which is involved in gliding motility and T4P extrusion, which in turn was 
shown to be influenced by C-di-GMP synthesised by DgcB (red square).  CdgA 
interacts with RomR (yellow circle), TPR Bd2492 (burgundy circle), and along 
with MglA (dark blue circle) are believed to regulate the TamAB transporter 
proteins (purple and green) at the anterior biting pole of the Bdellovibrio. 
[Figure modified from Hobley et al., 2012 and Milner et al., 2014] 
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7.4 Proteins of interest for the project 
Bd1483, a protein implicated in prey recognition  
The interconnectivity of gliding motility, T4P and enzyme secretion still requires the 
discovery of a stimulus, from prey ‘biting’ or attachment. This is where Bd1483 has 
been implicated. Bd1483 is a secreted von Willebrand type a (vWA) domain 
containing protein (Dori-Bachash et al., 2008, Medina et al., 2008). The signal 
peptide, required for secretion is found at the N-terminal end, and the vWA domain is 
found between residues Iso42 and Thr92 (figure 4a). Von WA domains were 
discovered in eukaryotes and have been implicated in adhesion and complement 
activation, while in bacteria they have been implicated in platelet aggregation in 
Streptococcus spp (Fitzgerald et al., 2006, Springer, 2006). Von WA domains often 
have a conserved motif that mediates binding of a divalent cation (Springer 2006). 
This motif, known as a Metal-Ion Dependent Adhesion Site (MIDAS), is required for 
ligand binding, and is found in integrins (Springer 2006). Along with their role in cell-
cell adhesion, vWA domains have been implicated in the gliding motility and invasive 
capabilities of the human pathogen Toxoplasmsa gondii (Song et al., 2012, Song and 
Springer, 2014). In Bdellovibrio there is no known external stimuli know to induce 
invasion through C-di-GMP signalling. Therefore, with Bd1483 being a secreted 
protein associated with adhesion and gliding motility in other invasive organisms it 
could be a mediator in the recognition of prey. It may bind directly to components of 
the prey’s outer membrane, or could be involved in the signalling transduction from 
the ‘biting’ protein internal signalling, through an, as yet unknown, membrane bound 
partner. This is suggested because bd1483 knockout mutants have been shown to 
be unable to predate upon biofilms (Medina et al., 2008). This signal could be 
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transmitted to cytoplasmic PilZ-(DUF4339) GYF domain proteins, specifically Bd1482 
(expressed within the same operon). This localisation of vWA, PilZ/GYF proteins on 
the same operon have been replicated elsewhere in the genome, Bd3099 (vWA) 
Bd3100 (PilZ/GYF). To add to this it has been shown through bacterial two hybrid 
experiments that Bd3100 interacts with DgcA, the GGDEF domain protein that has 
been implicated in gliding motility out of the prey (Pers. Comms. Lovering 2014).  
Bd1996 and Bd3100, predicted C-di-GMP and polyproline binding proteins   
Both Bd3100 and Bd1996 are PilZ domain containing proteins with DUF4339 
(domain of unknown function) accessory domains (2 in Bd3100 and 1 in Bd1996) 
(Figure 4b and 4c). Through protein threading these DUF4339 domains have been 
shown, to harbour putative glycine-tyrosine-phenylalanine (GYF) domains, which are 
known to bind polyproline rich sequences (PRS) (Kofler et al., 2005; Ash et al., 
2010). They have also been found in M. xanthus genes involved in adventurous 
gliding motility regulation. GYF domains have been attributed to regulating 
riboswitches and splicing machinery in eukaryotes, specifically in binding of the U5 
ribonucleoprotein (Balaji and Aravind, 2007). They contain a conserved W-X-Y-X6-11-
GPF-X4-M-X2-W-X3-GYF, found in the RAGNYA fold of which other RNA associated 
binding motifs are found. A minimal consensus sequence of proline-proline-glycine 
and been shown to be required for GYF binding (Balaji and Aravind, 2007). While 
many bacterial GYF domains have flanking polyproline residues there are none of 
these obviously in Bd3100 or Bd1996. GYF domains have been found in numbers 
across all bacterial lineages, especially α-proteobacteria, but are absent in Archaea 
(Balaji and Aravind, 2007). Along with this, it is suggested that eukaryotic GYF 
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domains may have originated from the α-proteobacteria that are the ancestors of 
modern day mitochondrion (Balaji and Aravind, 2007).  
 Bd3100 is 275 amino acids long and has a molecular weight of 31.1 kDa. It contains 
two PilZ, C-di-GMP recognition, domains, spanning Gln16 to Leu60 and Glu95 to 
Arg138, as well as a DUF4339 (GYF) domain spanning from Arg167 to Thr271 
(figure 4B). Bd3100 has been shown to interact with Bd0367 along with being shown 
to localise to the anterior pole of the cell, through fluorescent tagging (Pers Comms 
Lovering 2014). Previous attempt to express and purify this protein have led to the 
formation of inclusion bodies, which solubilisation in chaotropic agent and 
subsequent refolding have not yielded any soluble product (unpublished data).   
Bd1996 is another PilZ domain containing protein, which is 227 amino acids in length 
with a molecular weight of 25.2 KDa. It contains one N-terminal DUF4339 domain 
from residue Asp5 to Try43 and the PilZ spanning Arg127 to Arg222 (figure 4C). This 
has also been shown by fluorescent tagging to localise at the anterior tip of 
Bdellovibrio, along with the homologues Bd3100 and Bd1482 (Pers comm Lovering 
2014). This protein has not, to current knowledge, been previously overexpressed in 
E. coli. So, this protein’s expression and solubility are unknown.   
Bd2538, a predicted lipid binding protein possibly involved with membrane 
degradation 
A fourth protein, Bd2538, is a 63 KDa protein that has been shown to contain a 
DUF2785 domain. Through protein threading this is believed to be a putative TULIP 
domain protein (figure 4D). TULIP (tubular lipid binding) domain proteins are 
commonplace in the innate immune systems of humans, being involved in 
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recognition and scavenging of bacterial lipids, predominantly lipopolysaccharides, as 
well as being involved in cholesterol metabolism in the blood (Kopec et al., 2011). 
Recently, TULIP-domain proteins have been implicated in catalysing the movement 
of lipids from the mitochondria to the endoplasmic reticulum and back (Kopec et al., 
2010; Schauder et al., 2014). This possibly implicates Bd2538 in pore formation, with 
the removal of lipids from the prey outer membrane. As with Bd1483 and Bd1996 
there has been no previous work on cloning, overexpression, or purification of this 
protein.   
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B) Bd3100 
 
C) Bd1996 
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Figure 4.  Domain diagrams of the projects investigated: Bd1483, Bd3100, 
Bd1996 and Bd2538.  
A) The domain diagram of Bd1483. The orange domain is predicted to be a von 
Willebrand domain that has been suggested to be involved recognition and gliding 
motility in Plasmodium spp.  
B) The domain diagram of Bd3100. The 2 N terminal DUF4339 domains (green) 
have been shown, through protein threading, to be predicted GYF domains, which 
are known to bind proline rich sequences. The 3rd domain, located towards the C 
terminus is a predicted PilZ domain (red). These domains have roles in C-di-GMP 
signalling and are often found in proteins with secondary domains that have a 
function.  
C) The domain diagram of Bd1996. Like Bd3100 it contains an N terminal 
DUF4339 domain along with a C terminal PilZ domain.  
D) The domain diagram of Bd2538. The DUF2785 domain (yellow) has been 
predicted, through protein threading, to a putative TULIP domain, which are 
known to bind lipids and could have implications for prey recognition.  
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7.5 Project aims 
The overall aim of this project is to clone, overexpress and purify Bd1483, Bd3100, 
Bd1996 and Bd2538. With the hope of using these purified recombinant proteins in 
crystal trials and other biochemical assays. This will hopefully provide us with 
information on the structure and function of these proteins, which can lead to 
information on the polyproline binding specificity of Bd3100 and Bd1996 and whether 
this binding is dependent on C-di-GMP binding. As well as the first possible 
structures of DUF4339 domains. For Bd1483, a structure will help predict its possible 
in vivo binding partner(s) and whether they are exogenous or endogenous. With this 
information these proteins could be fitted into the current model for C-di-GMP 
signalling involvement in prey biting to invasion (figure 3).   
8.0 Methods  
8.1 Constructs used in the study 
bd1996 – pET41c expression vector C-terminal hexa-histag (His6). 
pET41c is modified from the pET41 plasmid (NOVAGEN) with the glutathione-S-
transferase tag removed.  
bd1483 – pET26B expression vector with a periplasmic leader sequence and N-
terminal His6 tag. 
M13bd3100 – pET41c expression vector with a C-terminal His6 tag.  
bd2538 – pET41c expression vector C-terminal His6 tag. 
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8.2 Preparation and storage of cell lines.  
8.2.1 The making of competent cells 
Buffers used were filter sterilised through a 0.2 µm filter:- 
TBF1- pH 5.8    TFB2- pH 6.8 
100mM RbCl2    100mM CaCl2 
50mM MnCl2     15% Glycerol 
30mM Potassium Acetate 
10mM CaCl2 
15% Glycerol 
BL21* and DH5α stocks (Invitrogen) were streaked out for single colonies on 
antibiotic free LB agar and incubated overnight at 37°C. Single colonies of BL21* and 
DH5α were picked and used to inoculate 25 mL of sterile antibiotic free LB broth and 
grown overnight at 37°C. 1 mL of the overnight cultures were used to inoculate 100 
mL of LB broth, and grown at 37°C in and orbital shaker until OD600 reached 0.6. 
Cells were spun at 4000xg for 5 minutes and the supernatants were discarded. From 
then on cells were kept on ice at all times. Cells from the 100 mL of LB broth were re-
suspended in 30mL cold TFB1 and incubated on ice for 90 minutes and then pelleted 
again at 4000xg for 5 minutes. The supernatants were discarded and re-suspended 
in 4 mL of TFB2. Aliquots of this were snap frozen in liquid nitrogen and stored at -
80°C.  
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8.3 Cloning of genes of interest 
8.3.1 Primers and restriction free cloning 
Primers for bd1996  
Forwards primer 
5’-GTTTAACTTTAAGAAGGAGATATACATATGAATCCAAAAAACTGGTCCGTGCTTAC-3’ 
Reverse primer 
5’-GCTGCACTACCGCGTGGCACAAGCTTAACCATGGCAAACTTGCGCACGTATT C-3’ 
Primers for the 1st and 2nd attempts of restriction free cloning of bd2538 
Forwards primer 
1: 5’-GTTTAACTTTAAGAAGATATACATATGACGGATGCCAATCCGCAGATTGC-3’ 
2: 5’-TTAACTTTAAGAAGGAGATATACATATGACGATGCCTTTCCGCAGATTGAAACAAG-
3’ 
Reverse primer 
1: 5’-GCTGCACTACCGCGTGGCACAAGCTTGTTTGCTCCTGTTTTCGCGTAATC-3’ 
2: 5’-GCTGCACTACCGCGTGGCACAAGCTTGTTTGCTCCTGTTTTC GCGTAATCCAGAAT 
AC-3’ 
Prior to the study the initial cloning and transformation of the pET26b-bd1483 
construct had been undertaken and colonies of transformed DH5α were stored at 
4°C ready for colony PCR and sequencing. Again, prior to the start of the study 
stocks of BL21* transformed with pET41c-M13bd3100, that were known to express 
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Bd3100, were prepared by Dr. Andrew Lovering. These cells were stored at -80°C 
and were used for all Bd3100 expression.  
Cloning was undertaken using restriction free methods previously described by van 
den Ent and Lowe, 2006, using primers, which have homologous sequences for both 
the gene of interest and destination vector. The product of the primary PCR was then 
used in the secondary PCR, which would incorporate the gene of interest into the 
destination plasmid, using the destination plasmid as a template for replication. This 
second round of amplification was then purified using Qaigen PCR clean up kit and 
eluted with 40µL of dH2O. Purified plasmids were concentrated from 40 µL to around 
15 µL using the Hetovac (Heto lab) VR-1 vacuum centrifuge. 
8.3.2 Transformation of competent bacterial strains  
120 µL of thawed competent E. coli DH5α cells (Invitrogen) were placed upon the 
concentrated plasmid and then incubated at 4°C for 30 minutes. Cells were then 
subjected to heat shock for 1 minute, at 42°C, then incubated for 1 hour at 4°C. 1 mL 
of antibiotic free LB broth was placed on top of the cells and the incubated for 1 hour 
at 37°C for recovery. The cultures were then spun at 4500xg for 1 minute and 100 µL 
of pelleted cells were plated out on kanamycin (50µg/mL) selective LB agar plates.  
Transformation of competent E. coli BL21* (DE3) cells (Invitrogen) were carried out in 
the same manner with the exception that 100 µL of BL21 * cells were transformed 
with 1.5 µL of sequenced plasmid containing the gene of interest. 
8.3.3 Colony PCR and sequencing 
To check whether transformed E. coli DH5α had up taken the plasmid of interest, 
PCR was undertaken on colonies that had grown overnight. Each reaction consisted 
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of 15 µL MyTaq Red mix 2X (Bioline), 2µL of pET21 forward and reverse primer mix 
and made up to a 30 µL total reaction volume, with sterilised dH2O. Colonies were 
picked with a sterile loop and spread across a kanamycin selective LB agar plate 
prior to the colony being placed in the reaction mixture. After PCR amplification, 6 µL 
of the product was run on a 1% agarose gel. Gels were imaged on an uvitec Alliance 
4.7 imager and analysed with UVIsoft.  
Colonies that contained an insert of correct size were picked for sequencing. 
Colonies were grown overnight in LB broth at 37 °C in an orbital shaker. Overnight 
cultures were minipreped as instructed by the Qaigen miniprep kit and plasmid eluted 
off the spin column with 50µL dH2O. Plasmids were sequenced at the functional 
genomics facility housed in the University of Birmingham. Plasmids that sequenced 
with the desired insert were stored at -20 °C.  
8.4 Expression of the genes of interest  
8.4.1 Small scale expression test  
Prior to full scale expression of recombinant protein, small scale trials were carried 
out to observe whether the recombinant proteins were soluble, and if not, whether 
changing the temperature during expression aided solubility. As well as this, both the 
media used was varied between 1x LB broth and 2X LB broth and the amount of 
inducing agent, isopropyl β-D-1-thiogalactopyranoside (IPTG), was varied to see 
whether this impacted expression of soluble/insoluble protein. 0.5 mL of overnight 
cultures with cells picked from colonies containing plasmid with sequenced gene of 
interest were used to inoculate 50 mL of test expression media (1x LB and 2X LB) 
and grown at 37°C in an orbital shaker, rotating at 200rpm until an optical density 0.6 
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at 600 nm was reached. Then, cultures were induced with varying amounts of 
isopropyl β-D-1-thiogalactopyranoside (IPTG), ranging from 25mM to 1000mM and 
cultures were grown at 18°C overnight for 18 hours in an orbital shaker at 200rpm. 
3mL samples of the cultures were taken at 5 hours and 24 hours post induction. 
Samples were spun at 6000xg for one minute to sediment the cells. Samples were 
lysed at room temperature in BugBuster for 1 hour and a 4µL sample was taken for 
SDS-PAGE analysis of the ‘whole cell’ (WC) fraction. The lysates were spun at 
17000xg and the supernatant containing the soluble components were sampled with 
4 µL and ran on a SDS-PAGE. To the samples, 16 µL of 2x SDS loading dye was 
added. Samples were boiled for 10 minutes at 100 °C and 10 µL of each sample was 
ran on SDS-PAGE at 150V for 30 minutes and stained with coomassie stain 
overnight at room temperature. 
8.4.2 Scale up expression of recombinant protein 
Initial overnight cultures, for expression tests, consisted of 5 mL sterile 1x LB broth, 
containing 50µg/mL kanamycin. Cultures were inoculated with a single picked colony 
of E. coli BL21* containing the desired plasmid insert and grown overnight in a 
shaker at 37°C.  
For all expressions 500 mL of 2x LB (50 µg/mL kanamycin) were inoculated with 5 
mL (1% inoculum) of the grown overnight culture and grown at 37°C in an orbital 
shaker at 200 rpm. Cultures were grown until they reached an OD600 of 0.5 and the 
induced with IPTG and grown overnight at 18°C. For expression of Bd1996 BL21 
cells were grown in 1xLB and induced with 50µM IPTG, cultures expressing Bd1483 
were induced with 50µM IPTG in 2xLB broth, while cultures expressing Bd3100 were 
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induced with 500µM IPTG in 2xLB broth. After 18 hours of expression cells were 
spun successively at 4500xg for 6 minutes (4°C) to pellet the cells. Cell pellets were 
stored at -20°C until required.  
8.4.3 Purification of over expressed protein 
8.4.3.1 Buffers for purification 
Buffer A – 20 mM Imidazole, 300 mM NaCl, 0.05% Tween 20 – pH 7.0 
Low imidazole buffer A – 5 mM Imidazole, 300 mM NaCl, 0.05% Tween 20 – pH 7.0 
Buffer B – 400 mM Imidazole, 300 mM NaCl, 0.05% Tween 20 – pH 7.0 
Buffer C – 20mM Imidazole, 300 mM NaCl, 0.05% Tween, 50mM EDTA – pH 7.0 
8.4.3.2 Purification  
Cell pellets were defrosted at room temperature in 30 mL of buffer A (Bd1996 and 
Bd3100) or low imidazole buffer A (Bd1483). Pellets were re-suspended at room 
temperature by rotating at 200 rpm in the presence of hen egg white lysozyme. Once 
re-suspended cells were lysed via sonication. With an output of 60% cells were 
sonicated for 20 seconds bursts and allowed to rest on ice for 2 minutes between 
bursts. This was repeated for 6 cycles. Once lysed the lysates were spun at 
40,000xg for 1 hour (4°C) (soft spin). The supernatant was decanted and, if needed, 
spun at 170,000xg for 1 hour (4°C) (hard spin) to pellet lipids. The clarified 
supernatants were passed over an equilibrated 1 mL HisTrap FF IMAC column 
loaded with 100mM NiSO4 at a flow rate of 1mL/minute with a peristaltic pump. The 
flow through was collected for sampling on SDS-PAGE. 
The loaded column was then attached to the AKTA prime fast protein liquid 
chromatography protein purification system to elute off the target protein. The column 
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was washed with 20 mL of buffer A (or low imidazole Buffer A for Bd1483) to wash 
off none specifically bound protein. To elute non-specifically bound the column was 
washed with 10% buffer B. To fully elute Bd1483, the column was washed with 20 
mL of 100% buffer B. To elute Bd1996, 15 mL of Buffer C was passed over the 
column due to high concentrations of imidazole causing Bd1996 to precipitate after 
elution. Throughout the duration of purification the eluent was analysed for protein 
content by measuring absorbance at 280nm. At all points of purification on the FPLC 
the eluents were retained in 5 mL fractions, fractions containing target protein were 
immediately placed on ice.  
8.4.4 Buffer exchange and concentrating of target protein  
FPLC fractions containing target protein were placed in dialysis tubing (MWCO 
10,000 Daltons) and dialysed overnight in 20mM HEPES (pH 7.0) and 200mM NaCl, 
or 20mM BIS-TRIS (pH 6.5) and 200mM NaCl. To concentrate the target protein after 
dialysis, the proteins were spun in Vivaspin-20 centrifugal concentrators at 2900xg 
(4°C) until protein reached a concentration between 20-35mg/mL. Once 
concentrated, the proteins were snap frozen in liquid nitrogen and stored at -80°C 
until use.  
8.4.5 Initial screening of target protein for crystallization 
Concentrated target proteins were initially screened for crystallisation using screens 
obtained from Molecular Dimensions via sitting drop method at 18°C. Drops 
consisted of 2 µL of protein solution mixed thoroughly with 2 µL of reservoir solution. 
Trays were checked at regular intervals for crystal growth. 
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Screens used for crystallization were all obtained from Molecular Dimensions: 
JCSG+, MIDAS, Proplex and Pact premier.  
8.4.6 Custom screening of initial hits 
To hits found in the initial trials factorial screens varying; the buffer pH, concentration 
of salt and precipitant, were undertaken. Throughout the optimization, variations in 
drop size as well as the addition of additives (10 mM Xylitol, 10% ethanol and 10mM 
IPTG) were investigated. Generally custom tray drops were trialled with the hanging 
drop method with 2 µL of protein solution mixed with 2 µL of the reservoir.  
 
8.4.6.1 Glycerol custom screen of Bd1483 
Glycerol was added to concentrate Bd1483 (34 mg/mL) to bring glycerol to a total 
weight per volume of 10% glycerol (protein at a concentration of 30.6 mg/mL). This 
was then screened against the JCSG+ sparse matrix. 120 µL reservoirs, sitting drop 
consisted of 2 µL reservoir and 2 µL protein, bringing the total w/v of glycerol to 5%. 
These were maintained at 18 °C.  
8.4.6.2 Sodium malonate/JCSG+ custom screen 
Reservoir solutions consisted of 108 µL 0.88 M sodium malonate, 0.11 M HEPES-
NaOH pH 7.0 and 0.55% Jeffamine M2005 (molecular dimensions) mixed with 12 µL 
of JCSG+ screen. This brought the overall reservoir concentration to 0.8 M sodium 
malonate, 0.1 M HEPES-NaOH pH 7.0 and 0.5% jeffamine M2005 with the JSCG+ 
as a 10% additive. Crystallization was trailed by sitting drop method with 2 µL protein 
solution mixed thoroughly with 2 µL reservoir solution.  
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All images of crystals were taken on a high-definition colour camera head DS-Fi2 
with a Nikon DS L3 microscope control unit. 
8.4.6 Cryoprotection of Bd1483 crystals 
Cryoprotection was achieved by supplementing the mother liquor with 20% ethylene 
glycol in 0.2M magnesium formate and 20% PEG 3350, from which Bd1483 crystals 
were seen in. When crystals were extracted they were flash cooled in liquid nitrogen, 
prior to being sent to the Diamond light source for data collection. 
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9.0 Results 
9.1 Expression and refolding of the suspected C-di-GMP binding protein, 
Bd3100 
9.1.1 Test expression of Bd3100 showed it to be insoluble across all tested 
conditions 
To hopefully optimise the overexpression of Bd3100 before scaling up to 3 litres of 
culture, small-scale expressions were carried out in 15mL of LB. These conditions 
varied the concentration of IPTG used to induce expression. As figure 5 shows, in all 
whole cell fractions, both at 5 hours (figure 5A) after induction and 24 hours (figure 
5B) after induction, Bd3100 remains insoluble, forming inclusion bodies. This is true 
for all conditions tested.   
When Bd3100 was expressed the presence of varying amounts of glycylglycine, no 
improvement of soluble Bd3100 after 18 hour induction was observed (Figure 6). 
This was the case for all concentrations of glycylglycine tested. As shown in figure 6a 
the soluble fractions showed no major band at 31 kDa, while this band was found in 
all whole cell fractions (figure 6b). This shows that glycylglycine does not affect the 
solubility of this protein, as it has done for others (Ghosh et al., 2004). These results 
led to changing the focus of Bd3100 expression from improve the solubility of the 
protein, to denaturing and refolding inclusion bodies of Bd3100 
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Figure 5. Test expression of Bd3100 in varying conditions 5 and 24 hours 
after induction with IPTG at 18°C. 
A) A SDS-PAGE of whole cell vs. soluble supernatant of samples E. coli cultures 
expressing Bd3100, 5 hours post induction with IPTG.  Lanes 2, 4, 6 and 8 show 
samples of the whole cell fractions (WC) when cells have been lysed in 
BugBuster™.  Lanes 1, 3, 5 and 7 show the soluble supernatant fractions (SUP) 
once the whole has been spun at 13,000 rpm to remove insoluble debris. A band 
above the 25 kDa marker, representing Bd3100 (31kDa), can only be seen in the 
whole cell sample (Lanes 1, 3, and 5) while it is absent from the soluble 
supernatant fractions (Lanes 2, 4 and 6). This shows that at 5 hours post 
induction at 18 C Bd3100 expresses in an insoluble form at all concentrations of 
IPTG. 
B) An SDS-PAGE of whole cell vs. soluble supernatant of samples E. coli cultures 
expressing Bd3100, 24 hours post induction with IPTG.  Lanes 1, 3, 5 and 7 show 
samples of the whole cell fractions (EC) when cells have been lysed in 
BugBuster™.  Lanes 2, 4, 6 and 8 show the soluble supernatant fractions (SUP) 
once the whole has been spun at 13,000 rpm to remove insoluble debris. A band 
above the 25 kDa marker, representing Bd3100 (31kDa), can only be seen in the 
whole cell sample (Lanes 1, 3, and 5) while it is absent from the soluble 
supernatant fractions (Lanes 2, 4 and 6). This shows that at 24 hours post 
induction at 18 C Bd3100 expresses in an insoluble form at all concentrations of 
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  Figure 6.  Test expression of Bd3100 in media supplemented with sterile 
glycylglycine.  
A) An SDS-PAGE of the soluble supernatant of samples of E. coli cultures 
expressing Bd3100 in the presence of glycylglycine, 18 hours post induction with 
IPTG.  Cells were lysed in BugBuster™ and spun at 13,000 rpm to remove 
insoluble debris. A band above the 25 kDa marker, representing Bd3100 
(31kDa), cannot be seen any on the supernatant fraction which would indicate 
Bd3100 being soluble at all concentrations of glycylglycine.   
B) An SDS-PAGE of whole cell samples of E. coli cultures expressing Bd3100 in 
the presence of glycylglycine, 18 hours with IPTG.  Whole cell fractions when 
cells have been lysed in BugBuster™. A band above the 25 kDa marker, 
representing Bd3100 (31kDa), can be seen in the whole cell sample at every 
concentration of glycylglycine. This shows that at 18 hours post induction at 
Bd3100 expression is not hampered by the addition of glycylglycine. 
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9.1.2 On-column refolding of Bd3100 was unsuccessful 
Due to Bd3100 forming inclusion bodies, insoluble aggregations of overexpressed 
protein, we attempted to denature these inclusion bodies, solubilising the aggregated 
protein and purifying from that point. Once denatured, the protein would then be 
refolded in the correct conformation by removing the denaturing agent. In an attempt 
to refold the denatured target protein the supernatant was passed over the nickel 
charged column in denaturing conditions, 8M urea. While bound to the column, a 
buffer of a slowly decreasing denaturant gradient was passed over the column in an 
attempt to refold Bd3100. Once the buffer was at 0M urea the bound protein was 
eluted using 400mM imidazole (pH 7.0) and 200mM NaCl. When ran on an SDS-
PAGE (not shown) it appeared that the protein was not eluted off of the column. Due 
to this it can be assumed that the protein misfolded and remained on the column.  
9.1.3 Shock refolding of Bd3100 proved more successful but the protein was 
not pure 
Because the initial attempt at full scale refolding was not successful, a small scale 
approach was taken to discover what buffer, if any, would allow for the refolding of 
Bd3100 from a soluble denatured state to a folded soluble state. Following the 
refolding protocol set out by Vincentelli et al. 2004, a refolding screen was set up 
using a range of buffer (50 mM Sodium acetate pH 4.6, 50 mM MES pH 5.8, 50 mM 
CHES pH 9.0 and 50 mM TRIS-HCl pH 7.2) and a range of additives (100 mM KCl, 
200 mM NaCl, 100 mM non-detergents sulfobetaines, 1mM EDTA, 10 mM β-
mercaptoethanol and 20% glycerol). 100 µL of Bd3100 was added to each condition 
and fluorescence was measured at 340nm, to measure precipitation. Sodium acetate 
with NDSB, EDTA, β-ME and 20% glycerol proved best for soluble refolded protein 
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(table 1). Due to sodium acetate proving to be the best across all additives the 1 mL 
samples containing sodium acetate were kept at 4°C for 30 minutes and measured 
for optical density at 340 nm again, to see if precipitation had occurred (Table 1). 
After this incubation, the conditions, which proved to be most suitable for stable 
refolding, included those with the NDSB, EDTA, β-ME and 20% glycerol additives. 
Due to glycerol’s inhibitory effect on nucleation during crystallization we chose to not 
carry on with this condition. We chose to use the condition containing β-ME for large 
scale shock refolding. 20 mL of protein solution was shock refolded into 600 mL of 
50mM sodium acetate pH 4.6 and 10mM β-ME. This was left overnight at 4°C to 
equilibrate. One caveat to the use of sodium acetate is that you cannot purify with 
IMAC columns due to the pH of the buffer being too low, which would strip the 
column of nickel ions. As well as this, previous attempts at purification of Bd3100 by 
a fellow researcher in the group failed when inclusion bodies of Bd3100 were 
solubilised in 6 M GndHCl or 8 M urea. After overnight incubation, at 4°C, there was 
no visible precipitation, so concentration of the suspected Bd3100 began. 
Unfortunately, during concentration, the protein solution began to precipitate even 
when kept at 4°C and did not resolubilise when brought up to room temperature, like 
other proteins (Pers comms Dr. Ian Cadby). A 1 mL sample of the precipitated 
solution was run on a SDS-PAGE to check the purity of the sample (figure 7). As 
figure 7 shows Bd3100 was not completely pure, as shown by the two faint bands 
found in the sample.  
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OD 
measured 
at 340nm 
KCl 
100 mM 
NaCl 
200 mM 
NDSB 
100 mM 
EDTA 
1 mM  
β-ME 
10 mM 
Glycerol  
20% 
Na Acetate  
pH 4.6 
0.081 
0.180 
0.166 
0.430 
0.041 
0.076 
0.054 
0.070 
0.043 
0.070 
0.038 
0.063 
MES 
pH 5.5 
0.51 0.93 0.17 1.31 0.163 0.14 
TRIS-HCl 
pH 7.0 
1.22 1.12 1.34 0.891 1.076 1.284 
CHES  
pH 9.1 
0.841 0.88 1.34 1.41 0.755 1.27 
 
 
 
 
 
 
 
 
 
 
 
Table 1. The absorbance of protein precipitant at 340 nm when Bd3100 was 
refolded in 1 mL of buffer.  
Bd3100 was measured immediately at 340 nm after addition of 100 µL of Bd3100 
solution to the buffer screen (black). 30 minutes after refolding, fluorescence was 
measured again at 340 nm, to observe whether solubility was maintained (red). 
The conditions that proved best for refolding, both immediately and 30 minutes 
after refolding, were: 50 mM Na acetate pH 4.6, with the 1 mM EDTA, 10 mM β-
ME and 20% glycerol as additives.  
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Figure 7. The purity of Bd3100 post refolding from inclusion bodies without 
IMAC purification. 
A SDS-PAGE of refolded Bd3100. Bd3100, from inclusion material, was 
solubilised in 20 mM Tris-HCl, 500 mM NaCl, 2% triton™ X-100 and 6M 
guanidine hydrochloride and shock refolded in 600 mL 50 mM sodium acetate 
pH 4.6 and 10 mM β-ME. The lane labelled ‘Refolded Bd3100’ shows a sample 
of Bd3100 after concentration. Bd3100 is not pure as there is a band found 
above 25 kDa that represents Bd3100 (31kDa) there is also a band above it at a 
higher molecular weight.  
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9.2 Expression, purification and crystallization of the predicted binding protein, 
Bd1483 
9.2.1 Cloning of bd1483 was successful 
Initial cloning procedures, as well as initial transformations of E. coli DH5a with 
suspected pET26b-bd1483 constructs, had been previously carried out. Colony PCR 
was undertaken on DH5α colonies that were believed to contain the pET26b-bd1483 
plasmid. Of these, 4 colonies showed that insert DNA was present (figure 8 lanes 3, 
10, 11 and 12). These colonies were then grown overnight and samples sent off to 
the functional genomics facility in the University of Birmingham for sequencing. One 
of these plasmids was shown to have the correct sequence for bd1483 and this 
plasmid was then used for the transformation of BL21*.  
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Figure 8. An agarose gel of the colony PCR of suspected pET26b-bd1483 
transformants. 
A 1% agarose gel of the PCR conducted on suspected transformed E. coli DH5α 
transformed with pET26b-Bd1483. Lanes 3, 10, 11 and 12 show colonies that are 
resistant to the kanamycin LB agar plates that have taken up the pET26b-bd1483 
plasmid, with a band slightly above the 1 Kb marker. All other lanes have become 
kanamycin resistant through other mechanisms.  
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9.2.2 Bd1483 was shown expresses and remain soluble in all expression 
conditions tested 
To determine what growth conditions, if any, best allowed for the expression of 
soluble Bd1483, prior to full scale expression, test expressions were carried out on 
colonies that had been transformed with sequenced pET41c-bd1483 in 50mL of LB 
broth. Figure 9 shows that Bd1483 is soluble when expressed at 1x LB 50µM IPTG, 
2x LB 25µM IPTG, 2x LB 50µM IPTG and 2x LB 500µM IPTG. Expression was seen 
in all conditions tested with the greatest amount of soluble protein being observed in 
2x LB 25µM IPTG. So, this condition was used to scale up for full-scale expression of 
Bd1483 in 3 litres of culture.  
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Figure 9. Test expression of Bd1483 in E. coli BL21* 
A) A SDS-PAGE of whole cell versus soluble supernatant of samples E. coli 
BL21* cultures expressing Bd1483, 5 hours post induction with IPTG.  Lanes 2, 4, 
6 and 8 show samples of the whole cell fractions (WC) when cells have been 
lysed in BugBuster™.  Lanes 1, 3, 5 and 7 show the soluble supernatant (SUP) 
fractions once the whole has been spun at 17,000xg to remove insoluble debris. A 
band below the 40 kDa marker, representing Bd1483 (39kDa), can be seen in 
lanes 1 and 2 (25 µM IPTG, 2x LB broth), 5 and 6 (500 µM IPTG, 2x LB broth) and 
7 and 8 (1000µM IPTG, 2x LB broth) showing that after 5 hours post induction 
Bd1483 expression is soluble.  
B) A SDS-PAGE of whole cell vs. soluble supernatant of samples E. coli BL21* 
cultures expressing Bd1483, 18 hours post induction with IPTG.  Lanes 1, 3, 5 and 
7 show samples of the whole cell fractions (WC) when cells have been lysed in 
BugBuster™.  Lanes 2, 4, 6 and 8 show the soluble supernatant (SUP) fractions 
once the whole has been spun at 17,000xg to remove insoluble debris. A band 
below the 40 kDa marker, representing Bd1483 (39kDa), can be seen all lanes. 
This shows that, 18 hours after induction at 18°C, Bd1483 expression is soluble in 
all conditions tested.  
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9.2.3 Scale up expression of Bd1483 was successful but purification was found 
to be difficult due to the protein binding weakly to the nickel loaded column 
Upon the scale up of overexpression, Bd1483 expressed well and was found to be 
soluble, as it was in small-scale trials. Initially it was found to bind weakly to a nickel 
loaded IMAC column, with the majority of the target protein coming out in the flow 
through rather than binding to the column. This was seen when cells expressing 
Bd1483 were lysed in buffer A. To remedy this the flow through was diluted into 150 
mL of low imidazole buffer A (5mM imidazole) to bring total imidazole concentrations 
to below 10mM. The diluted flow though was passed over the column once again, 
and it was found to bind to the column. Due to this, all subsequent preparations of 
Bd1483 were lysed in low imidazole buffer A. When in a low imidazole buffer A, 
Bd1483 bound to the column and then eluted using a buffer consisting of low 
imidazole buffer A and 10% buffer B. Bd1483 eluted off the column at around <50mM 
imidazole. To remove any remaining bound Bd1483 the column was washed with 
100% buffer B. Figure 10b shows that there remains some strongly bound Bd1483, 
even after the majority has been eluted off at <50mM imidazole.  
After purification, it was found that in the presence of the high imidazole buffer B 
(400mM) Bd1483 crashed out of solution, if not quickly diluted with 50% low 
imidazole buffer A. This, along with a quick dialysis, helped lower the amount of 
Bd1483 that precipitated. During concentration of the protein it was found that 
Bd1483 could be concentrated between 30 to 34mg/mL, during the study.  
	  118	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50	  
50	  
10	  
15	  
1	   2	   3	   4	   5	   6	   7	   8	   9	  
20	  
25	  
40	  
10	  
15	  
20	  
25	  
40	  
MW	  
(kDa)	  
MW	  
(kDa)	   B 
A 
WC INS SUP FT |-­‐-­‐-­‐400mM-­‐-­‐-­‐-­‐|	  
|-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐45mM	  imidazole-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐|	  
	  119	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Full scale expression of Bd1483 in E. coli BL21* 
A) A SDS-PAGE showing the purification and expression of Bd1483. Lane 2 is 
the whole cell fractions taken after sonication. Lane 4 is the insoluble debris after 
centrifugation at 17,000xg. Lane 6 shows the soluble supernatant after 
centrifugation at 17,000xg. Lane 7 shows the flow through of the supernatant 
after it has been passed over a nickel loaded HisTrap column. Lanes 8 and 9 
show the elution of Bd1483 at 400 mM imidazole. The large band below 40 kDa 
represents Bd1483. 
B) A SDS-PAGE showing the purification of Bd1483. Lanes 1-7 show the elution 
of Bd1483 at 45mM imidazole in the elution buffer. The large band below 40 kDa 
represents Bd1483. While this scale up expression showed that Bd1483 remains 
soluble during scale-up the protein is relatively contaminated with other proteins. 
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9.2.4 Screening of conditions for Bd1483 crystallisation 
9.2.4.1 Initial screens proved promising, with many conditions yielding crystal 
formation 
To determine the structure of recombinant protein, via X-ray diffraction, the next 
requisite was to obtain protein crystals of Bd1483, which would be of high enough 
quality. Initial screening of Bd1483 was carried out with the JCSG+ buffer screen. 
This yielded promising results as after one week, of incubation at 18°C, with a 
number of hits being observed in various conditions. These have been summarised 
in figure 11. Hits B, I, J, K and M were followed up with custom screens but crystals 
that would diffract were not observed during the duration of the study  
After 2 months of incubation at 18°C 3D crystals were found in a condition of 0.2 M 
magnesium formate and 20% w/v PEG 3350 (pH was not identified) (figure 10 
condition b). This condition was then subjected to a factorial custom screen varying 
the pH of magnesium formate as well as the concentration of PEG 3350. This yielded 
no crystals of equal morphology as those found in the original hit, but these had not 
been incubating for a similar amount of time, as the original condition, by the end of 
the study.  
When Bd1483 was trialled in the MIDAS alternative precipitant screen 3 hits were 
observed: 
 Figure 12a: 30% w/v Polyacrylate 5100 sodium salt, 10% ethanol and 1 M MES-
NaOH pH 6 
Figure 12b: 10% w/v poly(vinyl pyrrolidone) K15, 0.2 M ammonium formate and 20% 
w/v PEG4000 
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Figure 12c: 15% w/v poly(vinyl pyrrolidone) K15, 0.1M TRIS-HCl pH 8.0 and 25% w/v 
PEG5000 MME 
As is shown in figure 12a, needles appear to begin forming barrels. Due to this we 
undertook custom screening of this condition but could not replicate the crystal 
morphologies again (data not shown).  
When Bd1483 was trialled in proplex no hits were observed over the course of the 
study. This was the case for Bd1483 when the protein was dialysed into a buffer of 
0.1 M TRIS-HCl pH 8.0 and 200mM NaCl, as well. In this buffer, Bd1483 precipitated 
quickly when trialled in JCSG+ and no hits were seen throughout the study.  
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Figure 11. Hits for Bd1483 observed from the JSCG+ screen.  
A) 0.1 M sodium acetate pH 5.5 and 20 % w/v PEG3000 
B) 0.2 M magnesium formate and 20 % w/v PEG 3350 
C) 0.2 M ammonium chloride and 20% w/v PEG 3350 
D) 0.1 M Bicine pH 9.0 and 20 % w/v PEG 6000 
E) 0.2 M NaCl, 0.1M phosphate/citrate 4.2 and 20 % w/v PEG 6000 
F) 0.2 M ammonium nitrate and 20% w/v 3350 
G) 10 % w/v PEG 1000 and 10 % w/v PEF 8000 
H) 0.1 M imidazole pH 8.0 and 10 % w/v PEG 8000 
I) 0.1 M MES pH 6.5 and 1.6 M magnesium sulphate 
J) 1.1 M Sodium maolnate, 0.1 M HEPES 7.0 and 0.5 % w/v Jeffamine ED-2001  
K) 0.02 M MgCl2, 0.1 M HEPES 7.5 and 22% w/v polyacrylic acid 5100 sodium 
salt 
L) 0.1 M BIS-TRIS pH 5.5 and 25 % w/v PEG 3350 
M) 0.2 M lithium sulphate, 0.1 M BIS-TRIS pH 5.5 and 25 % w/v PEG 3350 
N) 0.2 M magnesium chloride, 0.1 M BIS-TRIS pH 5.5 and 25 % w/v PEG 3350 
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Figure 12. Crystal hits for Bd1483 in the MIDAS screen. 
A) 30% w/v Polyacrylate 5100 sodium salt, 10% ethanol and 1 M MES-NaOH pH 6 
B) 10% w/v poly(vinyl pyrrolidone) K15, 0.2 M ammonium formate and 20% w/v 
PEG4000 
C) 15% w/v poly(vinyl pyrrolidone) K15, 0.1M TRIS-HCl pH 8.0 and 25% w/v 
PEG5000 MME 
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9.2.4.2 When 20% glycerol was added to JCSG+ screen no hits were seen  
Due to crystals of Bd1483 forming spherulites and needle clusters, 20% glycerol was 
added to each condition of the JCSG+ screen. The addition of glycerol to the screen 
was an attempt to slow down the rate of nucleation events occurring during 
incubation. Thus, improving the quality of single crystals in the drop. Unfortunately, 
with the addition of glycerol to the conditions, no hits were seen in the screen.  
9.2.4.3 Sodium malonate JCSG+ screen yield no crystals that were of better 
quality than those found in the initial screens  
Due to the crystals observed in conditions containing 0.8 M sodium malonate, 0.1 M 
HEPES pH 7.0 and 0.5 % v/v Jeffamine ED-2001/ M2005, Bd1483 was trialled in a 
96 well custom screen involving the addition of 10% JCSG+ screens to a 90% 0.8 M 
sodium malonate, 0.1 M HEPES pH 7.0 and 0.5 % v/v Jeffamine M2005 condition. 
This trial yielded hits, but none of these hits were better than that found in the original 
JCSG+ screen.  
9.2.4.4 EDTA treated Bd1483 was found to crystallise, but true crystals could 
not be obtained 
During the purification of Bd1483, the nickel loaded columns appeared to lose the 
nickel upon elution of the protein. With the possibility that Bd1483 was chelating Ni2+, 
and introducing heterogeneity into the purified protein, we attempted to introduce 
homogeneity to the protein by treating the sample with one divalent cation. To do this 
the purified protein was treated with 2 times the protein concentration of EDTA to 
remove any bound divalent cations. Before incubation with a single divalent cation 
species by dialysis, the EDTA-treated protein was trialled in JCSG+ to examine if 
crystals could be obtained in a cofactor free state. These yielded results after 48 
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hours in the condition containing 0.15 M potassium bromide 30 % w/v PEG 2000 
MME (figure 13a and b).  
  
 
 
 
9.2.4.5 Conditions containing Bd1483 treated with 10mM manganese chloride 
yielded suspected salt crystals.  
After treating Bd1483 with EDTA, the protein was dialysed for 3 hours in the 
presence of 10mM MnCl2. This was chosen as other vWA domain containing proteins 
have been shown to bind this divalent cation, and its limited availability in the growth 
media may have introduced heterogeneity into the original protein sample. Screening 
of this protein was undertaken in JCSG+ and after 2 days incubation 1 hit was 
observed (figure 14). This hit was found in a condition of 0.1M sodium acetate pH 4.5 
and 1.0M di-ammonium hydrogen phosphate.  
 
 
Figure 13. Crystal hits of EDTA treated Bd1483 in JCSG+  
Both images are of Crystals of suspected Bd1483 in a condition of 0.15 M 
potassium bromide 30 % w/v PEG 2000 MME.  
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9.2.4.6 Conditions containing Bd1483 treated with 10mM magnesium chloride 
yielded suspected salt crystals  
As with the manganese treated Bd1483, protein was dialysed for 3 hours into 10mM 
MgCl2. This was also trialled in the JCSG+ screen and 2 hits were seen after 48 
hours. These hits were found in 0.2M sodium chloride/0.1M Na/K phosphate pH 6.2 
with 50% PEG 200 (figure 15a) and 0.1M sodium acetate pH 4.5 with 1.0M di-
ammonium hydrogen phosphate (figure 15b). As with the manganese treated 
Bd1483, these were also likely to be salt crystals and no further investigation was 
undertaken.   
Figure 14. Crystal hits of 10 mM MnCl2 treated Bd1483 in JCSG+ screen 
One hit was obtained in this screen. But his may be due to salt formation rather 
than proteinaceous crystals.  
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9.2.4.7 Suspected Bd1483 crystals showed no diffraction  
With the crystals of suspected Bd1483 found in 0.2M magnesium formate and 20% 
PEG 3350 showing promise for proteinaceous crystals that may diffract (figure 11B), 
these crystals were cryoprotected, looped from the drop, flash frozen and sent to 
Diamond light source for data collection. Unfortunately, no diffraction spots were 
detected for any of the crystals that were sent (data not shown).  
 
Figure 15.  Crystal hits found in JCSG+ when trailing 10mM MgCl2 treated 
Bd1483 
A) 0.2M sodium chloride/0.1M Na/K phosphate pH 6.2 with 50% PEG 200 
B) 0.1M sodium acetate at pH 4.5 and 1.0M di-ammonium hydrogen phosphate 
Unfortunately both of these hits can be attributed to phosphate crystals.  
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9.3 Cloning, expression, expression and crystallization studies of the 
suspected C-di-GMP binding protein, Bd1996 
9.3.1 Cloning of bd1996 proved successful 
To clone our gene of interest, bd1996, from the genomic DNA of Bdellovibrio 
bacteriovorus HD100, PCR amplification was undertaken using primers specific for 
the bd1996 gene. This product was then used for further cloning. Primary PCR 
amplification was undertaken using the velocity enzyme. This proved successful 
(lane 7, 9 and 10 of figure 16A). This primary product was then purified and used in a 
secondary PCR to clone the bd1996 gene into the pET41c plasmid. After Dpn1 
treatment and purification, E. coli DH5α cells were transformed with the purified 
plasmid. Colonies were picked and subjected to colony PCR amplification to see if 
the up taken plasmid had the insert of the gene of interest, which would show as a 
band above the 0.5 kb marker. Of the 6 transformed colonies 2 showed that insert 
DNA was present (Lane 7 and 9 of figure 16B). These colonies were then grown 
overnight and samples of purified plasmids sent off to the functional genomics facility 
in the University of Birmingham for sequencing. One of these plasmids were shown 
to have the correct sequence for bd1996 and this plasmid was used to transform E. 
coli BL21*. 
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Figure 16.  Agarose gels of PCR products during the cloning of bd1996.  
A) A 1% agarose gel showing the primary PCR product of bd1996 amplification in 
lanes 7, 9 and 10. Lanes 1-4 shows non-related results while lanes 7-10 show 4 
PCR reactions attempting to clone bd1996. These products were then used for 
secondary PCR in the presence of the pET41c plasmid. Unfortunately, the 
marker and samples as a whole had not run correctly so the marker cannot be 
used to label the gel accurately. 	  
B) A 1% agarose gel of the PCR conducted on suspected transformed E. coli 
DH5α transformed with pET41c-bd1996 on lanes 7-12. Lanes 7 and 9 show 
colonies that are resistant to the kanamycin LB agar plates that have taken up the 
pET41c plasmid, with a band near the 1 Kb marker. All other lanes have become 
kanamycin resistant through some other mechanism.  
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9.3.2 Test expression of Bd1996 showed that Bd1996 was possibly insoluble 
upon overexpression 
Test expressions were carried out to check the solubility of Bd1996. This was 
undertaken to hopefully optimise expression before scaling to litres of culture. Figure 
17 shows the SDS PAGE analysis out of the test expressions in different conditions. 
As figure 17 shows that in all conditions tested, Bd1996, was expressed with a band 
seen at roughly 27 kDa in the whole cell fraction, with an induction of 1000µM IPTG 
showing greatest amount of expression after 5 hours of expression (figure 17A). 
Expression was low in the soluble fractions (lanes 2, 4, 6, 8) indicating that this 
protein, as with other previously studied PilZ/DUF4339 domain proteins (Bd3100), 
had a low solubility when over expressed in E. coli BL21*. This was also seen after 
overnight incubation at 18°C. Figure 17b shows the expression of Bd1996 after 18 
hours of incubation at 18°C, in the lanes containing whole cell samples (1, 3, 5 and 7) 
there is overexpression of Bd1996 at 27kDa. Oddly, overexpression with 1000µM 
IPTG yielded less protein when analysed by SDS-PAGE. As with the time point taken 
at 5 hours post induction, there appears to be little Bd1996 found in the soluble 
fraction, with most soluble protein being seen in the condition where cells were grown 
in 2x strength LB broth and induced with 25 µM IPTG. Even though expression of 
soluble protein seemed low we decided to carry on with full scale expression, 
growing cultures in 2x strength LB broth, inducing with 25 µM IPTG and incubating 
overnight at 18°C. 
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Figure 17.  Test expressions of Bd1996 in E. coli Bl21*.  
A) A SDS-PAGE of whole cell vs. soluble supernatant of samples E. coli BL21* 
cultures expressing Bd1996, 5 hours post induction with IPTG.  Lanes 1, 3, 5 and 
7 show samples of the whole cell fractions when cells have been lysed in 
BugBuster™.  Lanes 2, 4, 6 and 8 show the soluble supernatant fractions once 
the whole has been spun at 17,000xg to remove insoluble debris. A band below 
the 25 kDa marker, representing Bd1996 (27kDa), can be seen in lanes 1 (50 µM 
IPTG, 1x LB broth), 3 (25µM IPTG, 2xLB broth), 5 (50 µM IPTG, 2x LB broth) and 
7 (500µM IPTG, 2x LB broth). Due to the absence of a band at 25 kDA in the 
soluble supernatants these SDS-PAGEs suggest that after 5 hours post induction 
Bd1996 expression is insoluble.  
B) A SDS-PAGE of whole cell vs. soluble supernatant of samples E. coli BL21* 
cultures expressing Bd1996, 24 hours post induction with IPTG.  Lanes 1, 3, 5 
and 7 show samples of the whole cell fractions (WC) when cells have been lysed 
in BugBuster™.  Lanes 2, 4, 6 and 8 show the soluble supernatant (SUP) 
fractions once the whole has been spun at 17,000xg to remove insoluble debris. 
A band below the 25 kDa marker, representing Bd1996 (27kDa), can be seen in 
lanes 1, 3, 5 and 7, the whole cell fractions. This suggests that 24 hours after 
induction at 18 C Bd1996 expresses insoluble in all conditions tested.  
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9.3.3 Bd1996 expresses as a soluble protein upon scale up, but the stability of 
Bd1996 is dependant upon the buffer 
When expression was scaled up, cells were lysed, spun down and supernatants 
passed over a HisTrap FF IMAC. Initial purification was undertaken using buffer B to 
elute Bd1996 off of the column. Bd1996 eluted off the column at 10% buffer B (≈80 
mM imidazole) and 100% buffer B (400mM imidazole). It was noted that if fractions 
containing Bd1996 were left in the high imidazole buffer B these fraction would 
precipitate shortly after elution, even at 4°C. When the precipitant was pelleted and 
soluble fraction dialysed into a low imidazole buffer the protein remained unstable, 
and once concentrated to 22mg/mL it continued to precipitate out of solution. SDS-
PAGE analysis of the purification, shown in figure 18b, shows that the 100% 
imidazole elution was not pure. Although a large band at around 27 kDa can be seen, 
which is found in the other elution fractions, and is at the correct size for Bd1996, 
contaminants can also be seen in the sample. Even though this purification provided 
unstable protein that crashed when screened in crystallization trials, it shows that 
Bd1996 is indeed soluble, contrary to what the expression tests suggested.  
To avoid the precipitative effects that imidazole exerts on proteins when in high 
concentrations, further purifications of Bd1996 were carried out in the same manner 
with the elution of protein at 10% buffer B. The final elution, to remove all bound 
protein, was carried out using buffer C (containing 50mM EDTA) to strip the column 
of nickel ions, therefore, eluting the rest of the bound protein. When the final elution 
was carried out in buffer C the eluted protein was more stable and did not precipitate 
upon elution. As shown by figure 19 this final elution step (buffer C) proves to be 
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more pure than the previous purification. With concentrated Bd1996, that was stable, 
crystal trials were undertaken.  
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Figure 18.  Scale-up expression of Bd1996 
A) An SDS-PAGE showing the purification and expression of Bd1996. Lane 2 is 
the whole cell fractions taken after sonication. Lane 4 is the insoluble debris after 
centrifugation at 17,000xg. Lane 6 shows the soluble supernatant after 
centrifugation at 17,000xg. Lane 7 shows the flow through of the supernatant 
after it has been passed over a nickel loaded HisTrap column. Lanes 8 and 9 
show the elution of Bd1483 at ≈80 mM imidazole. The large band below 25 kDa 
represents Bd1996. 
B) An SDS-PAGE showing the purification of Bd1996. Lanes 1-6 show the elution 
of Bd1996 at 80 mM imidazole. The large band below 25 kDa represents Bd1996. 
Lanes 7-9 show the elution at 400mM imidazole. This scale up expression shows 
that Bd1996 is soluble and bind relatively tightly to the HisTrap column, but when 
eluted with 400mM imidazole contaminants are eluted with it. 
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Figure 19.  Elution of Bd1996 with buffer C.  
An SDS-PAGE of the expression and purification of Bd1996, when eluted with 
buffer C. Lanes 1, 2, 3 and 4 represent the whole cell fraction, insoluble material, 
supernatant (after centrifugation at 17,000xg) and flow through of the supernatant 
(after being passed over a nickel loaded IMAC column), respectively. Lanes 5-8 
show the fractions of elution with 80 mM imidazole. Lane 9 shows the elution of 
Bd1996 with buffer C.  
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9.3.4 Crystallisation screens of Bd1996 yielded conditions that showed the 
beginnings of crystal formation, but these conditions could not be optimised 
As with Bd1483, we required crystals of Bd1996 for x-ray diffraction, to decipher the 
structure this protein’s structure. So, to discover what conditions yielded the best 
quality of crystal, trialling of buffer conditions was undertaken. When screening 
Bd1996, the initial protein stock was unstable and trials in JCSG+ proved unfruitful 
with the majority of the conditions precipitating instantly or overnight. Due to this, a 
trial in the proplex buffer screen was undertaken. Unfortunately, this led to 
precipitation in the drop immediately or overnight.  
With stable protein stocks (22 mg/mL), trials in JCSG+ yielded better results. Even 
though a lot of conditions precipitated immediately those that did not precipitate, 
generally, remained stable overnight and further. This was also seen when Bd1996 
was trailed in the MIDAS screen. After 1 month of incubation at 18°C crystal shards 
were observed in 0.1M BIS-TRIS, pH 5.5 and 0.3M magnesium formate (figure 20). 
This condition was then optimised by undertaking a factorial screen by ranging the 
pH of the BIS-TRIS buffer from 5.5 to 7.2, and varying the amount of magnesium 
formate from 0 M to 0.5M. At the time of writing there has been no replication of 
crystal shards in the custom tray.  
When Bd1996 was dialysed into the BIS-TRIS pH 6.5 and 200mM magnesium 
formate buffer, as suggested by the thermal shift buffer screen, trials in JCSG+ and 
MIDAS were undertaken. These conditions remained more stable than previous, with 
less causing precipitation of Bd1996, but at the time of writing there have been no 
observed crystals in these conditions.  
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Figure 20.  Crystal hits of Bd1996 when trialled in JCSG+ screen. 
Shard like crystals found in condition 0.1M BIS-TRIS pH 5.5 and 0.3 M magnesium 
formate. 
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9.4 Cloning of the suspected lipid binding protein, Bd2538 
9.4.1 Cloning and transformation of bd2538 plasmids proved difficult with no 
plasmid constructs being produced 
Initial cloning of bd2538 was undertaken, first-of-all, using the velocity enzyme with 
the PCR protocol that worked previously for bd1996. This proved unsuccessful, as 
there was no PCR product of the required length, ≈1.6 Kb, found on the gel (figure 
21A). This was repeated with and without the addition of DMSO to see if the DNA 
interfering nature of DMSO improves amplification with a touchdown PCR protocol, to 
find an annealing temperature that may produce product (figure 21B).  Due to the 
relatively high GC content of primers (67% forwards and 58% reverse) PCR 
amplification was attempted using the Phusion™ enzyme, with GC buffer that has 
been optimised for high GC content PCR and higher temperatures (figure 21C). 
Again, this proved unsuccessful as no product was produced. Due to this the primers 
were analysed using IDT oligo analyser web tool 
(http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/), which showed that the 
forwards primer had a high melting temperature of 63.6-72°C, and also produced 2° 
structures with itself, including hairpins, GC clamps and primer dimers. Due to this, 
one last attempt at producing PCR product with these was attempted using PFU 
polymerase before designing another bd2538 forwards primer. This polymerase has 
a greater thermo-stability, so, it could hopefully be used at higher temperature during 
extension. Reactions were carried out, with eight conditions at four temperatures, 
65°C, 60°C, 55°C, 50°C, with and without the addition of DMSO. No conditions 
attempted yielded PCR product (figure 21D).  
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Figure 21. The four attempts at the initial PCR amplification of the bd2538 
gene.  
A) A 1% agarose gel of the first attempt at PCR amplification of bd2538. Lanes 1-
3 were run with the velocity enzyme with an annealing step at 50oC, 580C and 
64oC, respectively. No PCR product was found.  
B) A 1% agarose gel of the PCR amplification of bd2538 using the Velocity™ 
enzyme in a touchdown protocol in the presence and absence of DMSO. Lanes 1 
(No DMSO) showed no product, neither did lane 2 (containing DMSO). 
C) A 1% agarose gel of the PCR amplification of bd2538 using the Phusion™ 
enzymes. Lanes 1-3 were run with an annealing step at 50oC, 58oC and 64oC, 
respectively. No PCR product was found. 
D) A 1% agarose gel of the PCR amplification of bd2538 using the PFU™ 
enzyme in the presence and absence of DMSO and in a touchdown protocol. 
Lanes 1-4 have no DMSO and show no product; neither did the conditions 
containing DMSO (6-10). 4 PCR amplifications each were carried at different 
temperatures annealing going: 65°C, 60°C, 55°C and 50°C, from left to right for 
both the no DMSO conditions and DMSO conditions 
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PCR was attempted with new a new forwards primer and was carried out by another 
researcher in the lab, this yielded PCR product. This product was then purified to 
remove the enzyme. Figure 22 A shows the gel of the PCR product after purification. 
This primary product was the used in secondary PCR to produce plasmid with the 
required insert. This secondary PCR product was then Dpn1 treated, purified and 
used to transform competent E. coli DH5α cells. Transformed cells were plated on 
kanamycin selective LB agar and incubated at room temperature for 60 hours. 
Colonies were spotted onto agar and used in colony PCR to look for the plasmid in 
these cells. Unfortunately, of the 3 colonies that were picked, none were shown to 
have taken up plasmid with the required insert (figure 22 B). 
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Figure 21 Agarose gels of PCR products during the cloning of bd2538 with 
new primers. 
A) A 1% agarose gel showing the purified primary PCR product of bd2538 in lane 
1. These products were then used for secondary PCR in the presence of the 
pET41c plasmid. Unfortunately due to an unfortunate omission of the ladder from 
the gel the size of the size of the primary product could not be determined.   
B) A 1% agarose gel of the PCR conducted on suspected transformed E. coli 
DH5α transformed with pET41c-bd2538. No lanes showed plasmid insert present. 	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10.0 Discussion  
Although no structures were determined by x-ray crystallography, or by other means, 
during the study, initial expression and purification of 2 previously unexpressed 
Bdellovibrio proteins, Bd1483 and Bd1996, had been undertaken in E. coli. 
Expression and crystallization conditions for the vWA domain containing protein, 
Bd1483, have been uncovered, a long with a single crystal that proved to be non-
diffracting. Bd1996, a putative C-di-GMP binding protein, has also been cloned, 
expressed and crystal trials were undertaken, with mixed results. Although Bd3100, 
another putative PilZ/GYF domain protein, remained insoluble when overexpressed 
we have described the initial attempts to refold Bd3100, with promising results that 
may lead to avenues of study.  
10.1 Bd3100 
10.1.1 Bd3100 expression is insoluble even when expression is optimised 
Even though previous studies (unpublished) showed that over expression of Bd3100 
aggregates into insoluble inclusion bodies, test expression were carried out to 
confirm this. Even with expression in low IPTG/temperature conditions inclusion 
bodies of insoluble Bd3100 were produced. Inclusion bodies can form when 
recombinant protein expression out speeds the rate at which native chaperones can 
accommodate and assist in the correct folding of nascent polypeptides being 
transcribed across the polyribosomal mRNA (Baneyx and Mujacic, 2004). If 
chaperones are limited, nascent polypeptide strands begin to interact with each other 
leading to misfolded polypeptides and aggregation as misfolded insoluble inclusion 
bodies. Other studies have shown how the co-expression of molecular chaperones 
allows for the expression of previously insoluble proteins (Nishihara et al., 1998; 
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Alderwick et al., 2008; Yan et al., 2012, Xu et al., 2014). While this may seem a good 
route of investigation the amount of time required to achieve this meant this avenue 
of investigation was out of the scope of this project. So, instead of co-expressing 
recombinant chaperones, we attempted to increase the expression of native 
chaperones by addition of glycylglycine to the growth media (Ghosh et al., 2004). 
Ghosh et al., have shown that the addition of glycylglycine to the growth media 
increases the solubility of previously insoluble proteins of mycobacterial origin, which 
are notorious for expressing as insoluble aggregates in E. coli. The authors attributed 
this to glycylglycine inducing an osmotic stress upon E. coli, as well as slowing down 
metabolism. Thusly, slowing down the translation of the over expressing protein. Due 
to this, we chose test whether the addition of glycylglycine, to the media, enhanced 
the solubility of Bd3100.  Unfortunately this did not improve the solubility of Bd3100 
at any of the concentrations tested, so focus was moved onto solubilising and 
refolding the inclusion material containing Bd3100.  
10.1.2 Shock refolding of Bd3100 yields soluble, but unstable, protein 
Seeing as all initial growth conditions tested produced inclusion bodies of Bd3100, 
which were not improved with the addition of glycylglycine, full-scale expression of 
Bd3100 went ahead in the condition that produced the greatest amount of inclusion 
material. The inclusion bodies were solubilised in 6M guanidine hydrochloride, a 
chaotropic agent that destabilises hydrophobic effects that cause proteins to fold by 
interrupting hydrogen bonding in water (Rashid et al., 2005). The buffer used for this 
contained 2% Triton X-100™ to hopefully free protein from membranes that are 
associated with inclusion body material. β-mercaptoethanol was added to the buffers 
to prevent the possible formation of disulphide bonds that would not be found in the 
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native protein, as this may lead to misfolded protein leading to precipitation (Monera 
et al, 1994). Initial refolding on the column did not yield soluble protein, in fact it was 
found to have precipitated on the column. So, a buffer screen of shock refolding 
conditions was undertaken. This proved initially successful with the sodium acetate 
buffers providing stable soluble protein upon shock refolding.  Upon scale up of the 
shock refolding in a 50 mM sodium acetate pH 4.6 and 1 mM β-ME, Bd3100 
remained soluble, but spin concentrating proved difficult and was lengthy. To the 
point where suspected Bd3100 was beginning to precipitate out of solution, even 
when stored at 4°C. In light of this we decided to check the purity of the suspected 
refolded Bd3100 and found that while there was Bd3100 present in the solution, it 
was not pure. This can be attributed to forgoing IMAC purification that had proven to 
be difficult with the unfolded Bd3100 when attempted by another researcher in the 
group. We decided to forgo this due to inclusion bodies generally being highly pure 
for the over expressed protein. Others have used this solubilisation of inclusion 
material without purification before, namely with overexpressed E. coli RNA 
polymerase (Burgess 1996). If time was not a limiting factor it would be interesting 
continue with the shock refolding method and begin optimisation. With soluble and 
presumably refolded Bd3100, it would be interesting to carry out ion exchange 
chromatography to remove the contaminating protein found in the inclusion bodies.  
10.1.3 Further work with Bd3100 
To check if the protein was refolded correctly, we could undertake circular dichroism 
on to study whether the composition of secondary structures in the refolded sample 
is similar to that of the predicted protein. This would be able to be undertaken even 
with a small yield of protein. If yield was large enough, crystallization screening could 
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be undertaken, along with biochemical characterisation such as size exclusion 
chromatography and analytical ultracentrifugation, to study whether this protein forms 
homodimers in the presence, or absence, of C-di-GMP. Along with this it may be 
possible to undertake pull-down experiments with Bdellovibrio lysate. This could be 
undertaken in the presence and absence of C-di-GMP, to see whether binding to 
native proteins is induced by conformational changes brought on by C-di-GMP 
binding, then mass spectrometry could be applied to the pulled down proteins to 
identify what Bd3100 binds in vivo. This could hopefully place Bd3100 in the C-di-
GMP signalling network.  
10.2 Bd1996 
10.2.1 Bd1996 expression is soluble but relatively unstable in the presence of 
imidazole 
 Bd1996 was soluble upon over expression and signifies the first time that a protein 
containing a PilZ domain and DUF4339 domain has been soluble when 
overexpressed in E. coli. Although, it precipitated overnight and remained unstable to 
begin with, this can be attributed to the high imidazole used to elute if off the IMAC 
column. This was remedied by eluting the protein off the column with EDTA. 
Imidazole can acts as a chaotropic agent at high concentrations, which can lead to 
protein precipitation, as in this case. Because of this, a buffer containing EDTA was 
used to chelate the nickel ions bound to the column. Therefore, eluting the bound 
protein off the column. This avoids the use of high concentrations of imidazole.  
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10.2.2 Crystallization of Bd1996 gave hits but could not be optimised to give 
diffractable crystals and further study. 
During the crystallization trials, conditions that showed crystal shard formation were 
optimised for crystal growth. These trials undertaken did not produce diffractable 
crystals. It is noted though; Bd1996 did not behave well in any the screens used, with 
a lot of the conditions leading to precipitation. This may need further study to try and 
improve stability, which may help in obtaining diffractable crystals. If crystallization is 
not possible, it may be possible to determine protein structure through other 
methods, such as nuclear magnetic resonance. Along with this it would be good to 
undertake similar biochemical characterisation as was suggested with Bd3100. 
Histag pull-downs with this protein and B. bacteriovorus lysates were planned, but 
due to time constraints they could not be completed during this study. This would be 
used to decipher the binding partners of Bd1996 and would help place Bd1996 into a 
model for C-di-GMP signalling. This would also give insight into how the DUF4339 
domains function in prokaryotes. As with Bd3100, analytical ultracentrifugation in the 
presence and absence of C-di-GMP could also be undertaken to investigate whether 
this protein forms homodimers, as many PilZ domain proteins do (Krasteva et al., 
2012).  
10.3 Bd2538 
10.3.1 Initial primers for bd2538 hampered initial efforts at cloning but altered 
primers remedied this  
As stated in the results, cloning of the suspected lipid binding protein proved difficult 
and unsuccessful. Initial cloning was halted due to the forwards primer forming 
secondary structures, such as GC clamps, hairpin loops and others, which prevented 
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amplification. Also, the forward primer melting temperature was excessively high. To 
remedy this, different DNA polymerases were investigated, to see if any of these 
were suitable. Different PCR reactions were attempted, such as touchdown, to no 
avail. After these showed no PCR product DMSO was added to the PCR. DMSO 
binds to cytosine nucleotides, decreasing the melting temperature of the primer, 
which is specifically useful in GC rich primers (Chester and Marshek, 1993, Jensen et 
al., 2010). DMSO also aids in preventing secondary primer structures such as, primer 
dimers and hairpin loops, but can lead to an increased mutational rate during PCR, 
although this is controversial (Hardjasa et al., 2010, Jensen et al., 2010). Even with 
the addition of DMSO primary PCR could not be obtained. So, an altered forwards 
primer was designed and used. This proved successful and produced primary 
product, which was then used to produce recombinant plasmid.  
10.3.2 Cloning of bd2538 could not be carried on past the initial plasmid 
Plasmid, suspected to have the bd2538 gene, was then used to transform competent 
DH5α. Three transformant colonies were obtained, but when these colonies were 
PCR amplified to check for an insert no insert was observed. This could be due to E. 
coli gaining a random mutation leading to kanamycin resistance or these colonies 
may have been transformed with pET41c that did not have the insert cloned into the 
plasmid.   
10.4 Bd1483 
10.4.1 Bd1483 expression is soluble and it crystalizes readily with non-
diffracting crystals.  
Bd1483 was soluble upon over expression and remained stable upon purification in a 
HEPES buffer, which allowed for crystal trials. These trials led to many hits. Most of 
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these hits were needle cluster, similar to sea urchin crystal morphologies, which were 
not useable for x-ray diffraction. Many of these conditions were then taken forward 
and optimised for crystal growth. These were all undertaken using a factorial screen 
altering the pH of the condition and the molarity of salt or additives. Unfortunately 
none of these optimisation trials yielded crystals that were better than that found in 
the original drops. Due to this we attempted to alter the original crystallization 
conditions in the Bd1483 screens. 
10.4.2 Altering the initial screening conditions of Bd1483 in JCSG+ led to 
interesting results 
10.4.2.1 The addition of glycerol to the screen inhibited crystallization 
 Due to the large amounts of needle clusters forming it was assumed that many 
nucleation events were taking place. So, to combat this we added 10% glycerol to 
each drop of a JCSG+ screen. Similar studies have shown that the addition of 
glycerol decreases the amount of nucleation allowing for true crystal formation (Vera 
et al., 2011). Unfortunately, this proved unsuccessful with no hits being seen over the 
study. This is probably due to glycerol’s property of stabilising proteins in solution 
therefore inhibiting nucleation (Vegende et al., 2009, Vera et al., 2011).  
10.4.2.2 The sodium malonate/JCSG+ screen did not improve hits that were 
previously seen 
Because the condition of 0.8 M sodium malonate, 0.1 M HEPES pH 7.0 and 0.5 % 
v/v Jeffamine ED-2001 yielded crystals in every JCSG+ screen undertaken, and 
showed hits in custom screens (although not as well formed as the original hit), it was 
decided that using this condition with a 10% supplementation of the other JSCG+ 
conditions may yield diffractable crystals. Although hits were seen in this screen, 
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none of these hits were usable for structure determination, nor did they surpass the 
original hits in the JCSG+ screen.  
10.4.2.3 Treating Bd1483 with EDTA and divalent cations did not improve 
crystallization 
Next, the effect of Bd1483 bound cofactors on crystallisation was examined. Other 
vWA containing proteins have been shown to bind divalent cations, notably Mg2+ and 
Mn2+ (Whittaker et al., 2002).  Due to the T7 polymerase’s requirement for Mg2+ this 
cation may be limited during overexpression leading Bd1483 to bind divalent cations 
that it would not normally bind with, for exampleNi2+ from the IMAC column. This may 
be one possible reason for the failure in producing diffracting Bd1483 crystals. To try 
and combat this Bd1483 was treated with EDTA to remove the bound divalent 
cofactor and then dialysed in a buffer supplemented with 10mM of a divalent cation, 
to hopefully obtain a solution of Bd1483 with homogenously bound cations. This was 
tested with both magnesium and manganese. When these dialysed proteins were 
trialled across JCSG+ screen crystals were seen after 2 days, but due to the 
conditions they were found in, along with crystal morphology, it was assumed that 
these crystals were salt and not proteinaceous. Crystal shards were seen in EDTA 
treated Bd1483, but these crystals could not be optimised further.  
10.4.3 0.2M magnesium formate with 20% PEG 3350 gave geometric crystals 
but these could not be repeated, nor did they diffract 
After 2 months of incubation at 18°C, suspected Bd1483 crystals were observed in 
0.2M magnesium formate with 20% PEG 3350. To try and replicate this two custom 
screens were carried out, one using a factorial screen varying the pH of the solution 
(molecular dimension state that magnesium formate has a pH of 7.6) and varying the 
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percentage of PEG 3350. One trial to decrease the amount of time for crystal 
formation, which from the original condition was 2.5 months, was attempted. The 
screen varying pH of the condition and percentage of PEG-3350 did not prove to 
yield crystals at the time of writing, but may yield crystals in the future. The second 
screen contained an increasing concentration of ammonium sulphate in the reservoir. 
This increasing concentration ammonium sulphate speeds up the rate of diffusion of 
water from the hanging drop, equilibrating the drop quicker. This proved unsuccessful 
with higher concentration of ammonium sulphate, in the reservoir, causing 
precipitation of Bd1483 in the drop. Crystals that were obtained in 0.2M magnesium 
formate with 20% PEG 3350 taken to the Diamond light source for data collection, 
but these crystals showed no diffraction.  
10.4.4 Further study of Bd1483  
Further study could be undertaken to obtain crystals that diffract. This would yield an 
opportunity to determine the structure of the vWA containing protein, and with this 
structure it may be possible to suggest what Bd1483 binds to, and whether or not it 
may be of prey or Bdellovibrio origin. As well as the continuation of crystallographic 
studies it would be interesting to characterise what Bd1483 binds to. This could be 
undertaken using histag pull-downs with Bdellovibrio and E. coli lysates. If Bd1483 
was found to bind proteins, when eluted of an IMAC column, mass spectrometry 
could be used to identify the co-purified partners. This would be interesting to see if 
Bd1483 binds prey or native proteins, which could help place this protein in the 
model for prey recognition leading to invasion.  
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11.0 Conclusion 
We have shown that Bd3100 is insoluble upon overexpression in E. coli, even when 
additives known to improve solubility are added, but shock refolding of denatured 
inclusion material in 0.1M sodium acetate supplemented with β-ME proved to yield 
soluble product. This remains to be optimised, with improvement to Bd3100 stability 
and purity needed. Bd1996 has been shown to be the first soluble protein that 
contains both the DUF4339 GYF-like and PilZ domains. Bd2538 remains to be 
cloned but a new forwards primer was shown to improve primary PCR amplification 
of the bd2538 gene. Bd1483 has been shown to overexpress as a soluble protein 
and crystalized readily. Although this also remains to be optimised, for crystals that 
will diffract. While this study has not been able to conclusively place any of the 
studied proteins into the prey recognition/invasion pathway it has laid the basis for 
further study into how these proteins control prey recognition, as well as how C-di-
GMP is involved in this signal.  With this information a model for how this interesting, 
and possibly medically relevant, bacterium undergoes predation and how C-di-GMP 
controls this could be described.  
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